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The risk of electromagnetic interference (EMI) with cardiac 
pacemakers and implantable cardioverter-defibrillators (ICDs) is of 
increasing concern in occupational environments. The number of 
workers with a pacemaker or ICD is growing rapidly. Knowledge 
is still insufficient concerning sources of EMI and the susceptibility 
of pacemakers and ICDs to electromagnetic fields (EMFs). In 
workplaces with strong EMFs, employees are often required to 
change tasks or retire after receiving a pacemaker/ICD. This study 
investigates the occurrence of EMI with pacemakers and ICDs 
in different magnetic fields and occupational environments and 
estimates potential EMF risks for an employee returning to work 
after a pacemaker/ICD implantation.
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3AbstrAct
Background
The risk of electromagnetic interference (EMI) to implanted cardiac 
rhythm devices such as pacemakers and cardioverter-defibrillators (ICDs) 
is causing increasing concern and problems in occupational environ-
ments. As the mean age of people receiving their first pacemaker or 
ICD is falling, the number of working-age people with these devices is 
growing. A major concern in workplaces is that all possible sources of 
EMI are not yet fully known.
The aims of this study were to find threshold magnetic field intensi-
ties for EMI with several commonly-used pacemaker and ICD models 
tested in vitro and to evaluate in vivo the susceptibility of pacemakers 
and ICDs to controlled electromagnetic fields (EMFs) generated in the 
laboratory. Volunteers with a pacemaker or ICD were also exposed to 
EMFs emitted by some electromagnetic applications found in real work 
environments in order to detect possible pacemaker/ICD malfunction. 
In addition, a case of an ICD EMI caused by a laptop computer was 
investigated.
Materials and methods
Sixteen pacemakers and 17 ICDs were exposed in vitro to magnetic fields 
with the frequency range of 2 Hz to 1 kHz produced by a computer-
controlled Helmholtz coil system. The magnetic fields used varied in 
intensity and had sinusoidal, pulse, ramp, and square waveforms. The 
highest exposure levels were chosen to comply with the occupational 
exposure reference levels for sinusoidal magnetic fields given by the Inter-
national Commission on Non-Ionizing Radiation Protection (ICNIRP) 
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in 1998. For non-sinusoidal waveforms the peak values were derived 
from these reference levels.
Eleven volunteers with a pacemaker and 13 with an ICD were ex-
posed in vivo to different magnetic fields with frequencies from 2 to 
200 Hz using similar waveforms and exposure system as in the in vitro 
tests. The magnetic flux densities ranged up to 300 µT. The volunteers 
were also exposed to EMFs emitted by an electronic anti-theft gate, an 
induction hob, and a metal inert gas (MIG) welding machine. All in 
vivo tests were performed with bipolar sensing configurations of the 
pacemakers tested. The pacemakers were tested with two programmed 
pacing settings: the basic rate programmed low enough to favour the 
subject’s intrinsic rhythm and high enough to result in 100% pacing. 
Three of the pacemakers were also tested with unipolar sensing settings. 
The unipolar pacemakers were programmed to pace with a rate higher 
than the subject’s intrinsic rhythm. Eleven volunteers with a pacemaker 
were exposed to EMFs near two mobile phone base stations, in an 
electric commuter train, and under high voltage transmission lines. 
In these tests, all pacemakers were programmed to normal clinically 
selected settings with bipolar sensing and pacing configurations. A case 
of an ICD EMI with a laptop computer was replicated with the same 
volunteer and computer.
Results
Malfunctions caused by the external magnetic fields occurred in six of 
the pacemakers and 11 of the ICDs tested in vitro. In most exposure 
situations, there was no EMI with the pacemakers or ICDs at magnetic 
field levels below the ICNIRP occupational safety limits. However, some 
frequencies using ramp or square-waveforms interfered with the function 
of the pacemakers even at levels below ICNIRP limits for public exposure. 
No EMI occurred with the ICDs below these limits. The occurrence of 
EMI depended greatly on the waveform, frequency, and intensity of 
the magnetic field. With the pacemakers, also the sensing configuration 
affected the occurrence of malfunctions. The pacemakers with unipolar 
sensing were more susceptible to interference than bipolar ones. In ad-
dition, magnetic fields perpendicular to the pacemaker generator and 
its electrode loops were more likely to cause EMI than parallel ones.
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None of the ICDs or pacemakers tested with bipolar sensing set-
tings experienced interference in any of the in vivo exposure situations. 
The three pacemakers tested with unipolar settings were affected by the 
magnetic fields of the Helmholtz coil, and one of them also by the EAS 
gate and the welding cable. The induction hob did not interfere with any 
of the unipolarly programmed pacemakers. The laptop computer EMI 
with an ICD was successfully replicated in the laboratory. The conversion 
of the ICD to magnet mode was found to be due to the static magnetic 
field produced by the hard disk of the laptop computer.
Conclusion
Pacemakers programmed with unipolar sensing configurations can cause 
danger to their users in environments with high EMFs, and should be 
avoided whenever possible. Laptop computers, positioned above an ICD, 
can cause EMI with the ICD. This interference may convert the ICD to 
magnet mode which is dangerous because it, temporarily or permanently, 
stops all tachyarrhythmia detections and therapies on most ICD models.
In the majority of workplaces, EMI with cardiac pacemakers or ICDs 
is unlikely. Magnetic fields with intensities as high as those used in this 
study are rare even in industrial working environments. However, an 
individual risk assessment shall be carried out when an employee returns 
to work after a pacemaker or ICD implantation.
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Ihmiseen asennettujen sydäntahdistimien riski häiriintyä sähkömag-
neettisissa kentissä huolestuttaa ja aiheuttaa ongelmia erilaisissa työym-
päristöissä. Koska tahdistimia asennetaan yhä nuoremmille henkilöille, 
työvoiman ikääntyessä yhä useammalla työntekijällä on tahdistin. 
Työpaikkojen suuri huolenaihe onkin, ettei kaikkia mahdollisia sähkö-
magneettisen häiriön lähteitä vielä tunneta täysin.
Tässä tutkimuksessa pyrittiin määrittämään magneettikentän voimak-
kuuden kynnysarvot useiden yleisesti käytettyjen hitaansykkeentahdisti-
mien (bradycardia pacemaker) ja rytmihäiriötahdistimien (implantable 
cardioverter-defibrillator, ICD) sähkömagneettisille häiriöille laboratorio-
olosuhteissa. Lisäksi arvioitiin koehenkilöiden tahdistimien herkkyyttä 
erilaisille laboratoriossa tuotetuille magneettikentille. Koehenkilöitä 
altistettiin myös todellisissa työympäristöissä käytettävien laitteiden 
aiheuttamille sähkömagneettisille kentille. Lisäksi tutkittiin tapausta, 
jossa kannettava tietokone aiheutti häiriötä rytmihäiriötahdistimen 
toiminnassa. 
Kokeessa 16 hitaansykkeen- ja 17 rytmihäiriötahdistinta upotettiin 
ihmisen kudosten sähköfysiologisia ominaisuuksia vastaavaan suola-
liuokseen ja altistettiin erilaisille magneettikentille taajuusalueella 2 Hz–1 
kHz. Magneettikentät tuotettiin tietokoneohjatulla kelasysteemillä ja ne 
vaihtelivat voimakkuudeltaan sekä aaltomuodoltaan. Voimakkuudeltaan 
korkeimmat altistustasot valittiin yhtä suuriksi kuin Kansainvälisen 
ionisoimattoman säteilyn komission (International Commission on 
Non-Ionizing Radiation Protection, ICNIRP) vuonna 1998 vahvistamat 
työntekijöiden altistumisen viitearvot sinimuotoisille magneettikentille. 
Muille kun siniaaltokentille johdettiin painotetut huippuarvot näistä 
viitearvoista. 
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Testeihin osallistui 11 koehenkilöä, joilla oli hitaansykkeentahdistin 
ja 13 henkilöä, joilla oli rytmihäiriötahdistin. Heidät altistettiin 2–200 
Hz taajuisille magneettikentille eri magneettivuon tiheyksillä aina 300 
µT asti. Altistussysteemi ja aaltomuodot olivat samat kuin pelkkien tah-
distimien testauksissa. Koehenkilöt altistettiin myös varashälytinportin, 
induktiolieden ja MIG-hitsauskaapelin aiheuttamille sähkömagneettisille 
kentille. Kaikki koehenkilötestit suoritettiin hitaansykkeentahdistimien 
tunnistuksen ollessa kaksinapaista. 
Hitaansykkeentahdistimet testattiin käyttämällä kahta eri tahdistus-
asetusta. Ensin tahdistuksen sykeraja ohjelmoitiin riittävän alas, jolloin 
tahdistin ei tahdistanut sydäntä lainkaan testien aikana. Seuraavaksi 
tahdistusraja ohjelmoitiin riittävän ylös, jolloin tahdistin tahdisti sydän-
tä koko ajan testien aikana. Kolme hitaansykkeentahdistinta testattiin 
lisäksi myös tunnistukseltaan yksinapaisina. Yksinapaisina testattaessa 
tahdistimet oli ohjelmoitu tahdistamaan koehenkilön sydäntä koko ajan. 
Tutkimuksessa 11 hitaansykkeentahdistimen käyttäjää altistettiin 
sähkömagneettisille kentille kahden matkapuhelinten tukiaseman lä-
heisyydessä, sähköjunassa ja suurjännitejohtojen alla. Näiden testien 
aikana tahdistimien asetuksia ei muutettu, vaan kaikki tahdistimet 
olivat ohjelmoituna normaaleille kliinisille asetuksilleen tunnistuksen 
ja tahdistuksen ollessa kaksinapaisia. Yhden koehenkilön havaitsema 
rytmihäiriötahdistimen häiriintymistilanne kannettavan tietokoneen 
läheisyydessä toistettiin saman koehenkilön ja tietokoneen kanssa.
Ulkoisten magneettikenttien aiheuttamia toimintahäiriöitä esiintyi 
kuudessa hitaansykkeentahdistimessa ja 11 rytmihäiriötahdistimessa, kun 
laitteet testattiin suolaliuoksessa. Suurimmassa osassa altistustilanteita 
sähkömagneettisia häiriöitä ei havaittu magneettikentän voimakkuuksien 
ollessa työntekijöille tarkoitettujen ICNIRP:n viitearvojen alapuolella. 
Kuitenkin joillain taajuuksilla hitaansykkeentahdistimet häiriintyivät 
jopa väestön altistumiselle asetettujen viitearvojen alapuolella käytettäessä 
nopeita kentänvoimakkuuden muutoksia sisältäviä ramppi- tai kantti-
aaltoja. Rytmihäiriötahdistimilla ei havaittu toimintahäiriöitä väestön 
viitearvojen  alapuolella. 
Sähkömagneettisten häiriöiden esiintyminen riippui suuresti käy-
tetyn magneettikentän aaltomuodosta, taajuudesta ja voimakkuudesta. 
Hitaansykkeentahdistimilla myös tunnistuksen napaisuus vaikutti 
häiriöiden ilmaantumiseen. Yksinapaiseen tunnistukseen ohjelmoidut 
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hitaansykkeentahdistimet olivat herkempiä häiriöille kuin kaksinapaisen 
tunnistuksen laitteet. Lisäksi sähkömagneettisten häiriöiden todennäköi-
syys oli suurempi tahdistinsysteemin (generaattorin ja elektrodijohtojen) 
muodostaman pinta-alan ollessa kohtisuoraan magneettikenttää vastaan 
kuin tahdistinsysteemin kanssa samansuuntaisissa kentissä.
Koehenkilöillä tehdyissä kokeissa yksikään rytmihäiriötahdistimista 
tai kaksinapaisen tunnistuksen hitaansykkeentahdistimista ei häiriinty-
nyt missään altistustilanteessa. Kaikki kolme yksinapaisella tunnistuk-
sella varustettua hitaansykkeentahdistinta häiriintyivät laboratoriossa 
tuotetuissa magneettikentissä ja yksi niistä lisäksi varashälytinportin 
ja hitsauskaapelin läheisyydessä. Induktioliesi ei aiheuttanut häiriöitä 
yhteenkään yksinapaiseen tahdistimeen. Kannettavan tietokoneen 
aiheuttama sähkömagneettinen häiriö rytmihäiriötahdistimen toimin-
nassa pystyttiin toistamaan laboratoriossa. Tahdistimen siirtyminen 
magneettitilaan johtui tietokoneen kovalevyn aiheuttamasta staattisesta 
magneettikentästä.
Tunnistukseltaan yksinapainen ohjelmointi hitaansykkeentahdisti-
missa voi aiheuttaa vaaraa ympäristöissä, joissa on voimakkaita sähkö-
magneettisia kenttiä. Siksi sitä tulisi välttää aina kun mahdollista. Kan-
nettavan tietokoneen käyttö makuuasennossa rytmihäiriötahdistimen 
päällä aiheutti sähkömagneettista häiriötä tahdistimen toimintaan. Tämä 
häiriö saattaa siirtää rytmihäiriötahdistimen magneettitilaan, jolloin suu-
rimmassa osassa tahdistinmalleista kaikki tahdistimen rytmihäiriöiden 
tunnistukset ja hoidot loppuvat hetkellisesti tai pysyvästi.
Tässä tutkimuksessa käytetyt varsin suuret magneettikenttien voimak-
kuudet ovat harvinaisia jopa teollisissa työympäristöissä. Suurimmassa 
osassa työpaikoista sydäntahdistimien sähkömagneettinen häiriintyminen 
on epätodennäköistä. Kuitenkin sydäntahdistimen asennuksen jälkeen 
on aina tärkeää tehdä yksilöllinen riskinarviointi ennen työntekijän 
paluuta työtehtäviinsä.
9list of AbbreviAtions 
AAI Atrial sensing and pacing
AC Alternating current
AMS Auto mode switch
ATP Anti-tachycardia pacing
bpm Beats per minute
CENELEC European Committee for Electrotechnical Standardiza-
tion (Comité Européen de Normalisation Electrotech-
nique)
CRT-D Cardiac resynchronizing therapy implantable cardioverter-
defibrillator (biventricular ICD)
CRT-P Cardiac resynchronizing therapy pacemaker (biventricular 
pacemaker)
DC Direct current
DDD Dual chamber (atrial and ventricular) sensing and pacing 
with atrioventricular synchrony
DDDR DDD, with a sensor that records a demand for higher 
cardiac output and can adjust the heart rate accordingly
DDI Dual chamber (atrial and ventricular) sensing and pacing 
without atrium synchronous ventricular pacing
DOO Asynchronous atrioventricular sequential pacing (noise 
mode)
EAS Electronic article surveillance
EC European Council
ECG Electrocardiography
EGM Electrogram
EMF Electromagnetic field
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list of AbbreviAtions
EMI Electromagnetic interference
EN European Norm
EU European Union
GSM Global System for Mobile Communications
FDA Food and Drug Administration of the United States
ICD Implantable cardioverter-defibrillator
ICNIRP International Commission on Non-Ionizing Radiation 
Protection
in vitro tests Tests performed with an explanded or demo-device pace-
maker/ICD without a human body, using a phantom or 
body simulator
in vivo tests Volunteer tests performed with an implanted pacemaker/
ICD
LVAD Left ventricular assist device
MIG Metal inert gas (welding)
MRI Magnetic resonance imaging
NaCl Sodium Chloride
NMES Neuromuscular electric stimulation
NMT Nordic Mobile Telephone
RF Radio frequency (100 kHz–300 GHz)
RFID Radiofrequency identification reader
rms Root-mean-square
RNS Repetitive nerve stimulation
RV Right ventricle
SAR Specific absorption rate
SD Standard deviation
SSI Either AAI or VVI
SSIR Either AAIR or VVIR
TENS Transcutaneous electric nerve stimulation
TETRA Terrestrial Trunked Radio
UMTS Universal Mobile Telecommunication System
U.S.   The United States
VDD Dual chamber (atrial and ventricular) sensing and ven-
tricular pacing
VF Ventricular fibrillation
VP Ventricular pacing
VS Ventricular sensing
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list of AbbreviAtions
VT Ventricular tachycardia
VVI Ventricular sensing and pacing
VVIR VVI with a sensor that records a demand for higher 
cardiac output and can adjust the heart rate accordingly
WHO World Health Organization
WLAN Wireless local area network
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list of symbols 
A Ampere
B Magnetic flux density, in Tesla [T] (1 µT = 10-3 mT = 
10-6 T)
Bpub ICNIRP reference level for public exposure to sinusoidal 
magnetic fields or the maximum peak limit for public 
exposure to non-sinusoidal magnetic fields, in per cent 
[%]. 
Bocc ICNIRP reference level for occupational exposure to 
sinusoidal magnetic fields or the maximum peak limit 
for occupational exposure to non-sinusoidal magnetic 
fields, in per cent [%]. 
Brms Root-mean-square value of magnetic flux density, in Tesla 
[T]
c Velocity of light, in metre per second [m/s] (2.998 x 108 
m/s in vacuum)
E Electric field strength, in Volt per metre [V/m]
f Frequency, in Hertz [Hz]
H Magnetic field strength, in Ampere per metre [A/m]
J Joule
λ Wavelength, in metre [m]
µ Magnetic permeability, in Henry per metre [H/m] (1.26 
x 10-6 H/m in vacuum)
SAR Specific absorption rate, in Watt per kilogramme [W/kg]
V Volt
W Watt
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1  InTRoducTIon
The number of people with an implanted cardiac pacemaker or cardio-
verter-defibrillator (ICD) is increasing as a consequence of the expanding 
indications for pacemaker/ICD treatment. At the same time, concern is 
growing with regard to electromagnetic compatibility of these devices. In 
Finland, over 900 pacemakers/ICDs per million citizens are implanted 
annually, and globally more than one million pacemakers and 300 000 
ICDs were implanted in 2009 [Annila 2010; Mond and Proclemer 2011]. 
Although many studies have been carried out concerning electromagnetic 
interference (EMI) of pacemakers and ICDs, it is not fully known how 
susceptible they really are to different external electromagnetic fields 
(EMFs). In workplaces with EMFs high enough to possibly interfere 
with pacemakers/ICDs, employees receiving active implanted cardiac 
devices are often required to change tasks or retire. These options may 
be expensive for the employer and for the society, as well as undesir-
able for the employee, especially in case of a young person. Therefore, 
minimizing the health risks arising from EMI in work environments is 
an economical and occupational safety challenge.
The new European EMF directive (2013/35/EU) has adapted the 
previous directive (2004/40/EC) in requiring employers to consider the 
health and safety of workers at particular risk [European Parliament and 
Council 2004; European Parliament and Council 2013]. Workers with a 
pacemaker or an ICD belong to this group. Currently, safety provisions for 
workers with a pacemaker/ICD exposed to EMFs are poorly understood.
Electromagnetic fields
Electromagnetic fields, emitted by electrical devices and applications, 
can potentially disturb the function of active implanted cardiac devices. 
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EMFs are a part of the non-ionizing radiation spectrum, including static 
electric and magnetic fields (0 Hz) and time-varying EMFs varying from 
1 Hz to 300 GHz. 
EMFs are characterized by their frequency (f ) and wavelength (λ), 
with units of hertz [Hz] and metre [m], respectively. These two quanti-
ties are related by the velocity of light (c):
f = c/λ
Magnetic fields are generated around moving charges and are character-
ized by two quantities: the magnetic field strength (H) expressed in am-
pere per metre [A/m] and the magnetic flux density (B) in units of tesla 
[T]. H and B are related by the magnetic permeability of the medium (µ):
B = µH
Electric charges produce an electric field around them even without 
flowing currents. The strength of an electric field (E) is expressed in volt 
per metre [V/m] [Hietanen et al. 2002].
Interaction mechanisms of EMFs with a human body depend on 
the frequency content of the fields. Static (0 Hz) magnetic fields have 
electrodynamical and magnetomechanical effects on the body. Elec-
trodynamical interactions with moving conductive tissue (e.g. cardiac 
contraction) induce electric fields and currents inside the body, whereas 
magnetomechanical interactions result in torques and forces on magnetic 
materials. In addition, static magnetic fields can affect electronic spin 
states of reaction intermediates. Static electric fields do not penetrate 
the body, but they can induce surface charges on conducting objects 
which may result in currents through the body when in contact with a 
grounded person [Hietanen et al. 2002; WHO 2006].
Time-varying, extremely low frequency (1 Hz–100 kHz) magnetic 
fields induce electric fields and circulating electric currents in the body, 
whereas electric fields with these frequencies produce a surface charge, 
which results in induced currents in the body [WHO 2007].
Radiofrequency (RF) electric and magnetic fields (100 kHz–300 
GHz) are coupled into cells and tissues, and energy is deposited or 
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absorbed in the biological system. Some effects may result from the 
induced fields and currents, but these mainly are associated with an 
elevation of tissue temperature from RF energy absorbed in biological 
systems. The generally accepted dosimetric quantity for RF exposure is 
specific absorption rate (SAR), with units of watt per kilogramme [W/
kg], which quantifies the energy transfer to the body per units of time 
and mass [ICNIRP and WHO 1999; Hietanen et al. 2002; Lin 2007 ]. 
International reference levels for the exposure to EMFs have been 
established by the International Commission on Non-Ionizing Radia-
tion Protection (ICNIRP). The reference levels are frequency dependent 
below the frequency of 3 kHz, and they have been derived separately 
for general public and occupational exposure. At the power frequency 
of 50 Hz, the newest ICNIRP reference levels for public exposure are 
200 µT (magnetic field) and 5 kV/m (electric field). Respectively, the 
reference levels for occupational exposure are 1 mT and 10 kV/m at 
50 Hz [ICNIRP 2010]. The first test series of this study was, however, 
carried out before these new guidelines were published, so that the valid 
older reference levels for general public and occupational exposure were 
applied. The old reference levels at 50 Hz for general public exposure 
were 100 µT and 5 kV/m, and for occupational exposure 500 µT and 
10 kV/m, respectively [ICNIRP 1998]. 
Pacemakers and implantable cardioverter-defibrillators (ICDs)
Bradycardia pacemakers are used to treat too low intrinsic heart rhythm. 
The pacemaker restores delayed or absent contraction of the heart. An 
artificial stimulus given by the pacemaker (duration of 0.4–1 ms, voltage 
of 2–5 V) activates the heart to contract locally and diffusing the whole 
myocardium. When the patient’s intrinsic heart rate decreases below the 
programmed base rate of the pacemaker, it starts to pace the heart at a 
set pacing rate. The aim is to repair the deprivations of the spontaneous 
rhythm by restoring the normal heart rate alternation and the cooperation 
of the ventricles and atriums without disturbing the heart’s own activity. 
A heart rate that is too low can lead to sudden loss of consciousness. A 
decreasing heart rate can also trigger sudden life threatening arrhythmias, 
such as ventricular fibrillation (VF). A continuous low heart rate can 
weaken the state of consciousness and lead to heart failure. When the 
intrinsic heart rate is higher than the pacemaker’s programmed base rate, 
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the pacemaker senses the intrinsic action and follows it without pacing 
the heart unnecessarily. In some cases, the pacemaker helps the heart 
rate to correctly adjust to physical effort [Allen 2006; Toivonen 2008]. 
The most common indications to pacemaker implantation are 
electric conductivity problems in myocardia (atrioventricular block), 
dysfunction in the sinus node (sick sinus syndrome), and reflex induced 
difficult bradycardias. The need of the pacemaker treatment is defined 
by the symptoms caused by the bradycardia, the danger of asystole, and 
bradycardia induced susceptibility for tachyarrhythmias. Bradycardia 
pacemakers can be divided into three different operating types: ven-
tricular pacemakers (VVI), which sense and pace the ventricle/ventricles, 
atrial pacemakers (AAI), which sense and pace the atrium/atriums, and 
physiological pacemakers (DDI, VDD, DDD), which maintain atrio-
ventricular collaboration. Bradycardia pacemakers can also be classified 
as single-chamber and dual-chamber devices. Single-chamber pacemakers 
contain one electrode lead attached to the right atrium or ventricle. In 
dual-chamber devices, one electrode is located to the right atrium and 
one to the right ventricle. A dual-chamber pacemaker may also have only 
one electrode lead which senses the activity between the right atrium 
and ventricle but paces only the right ventricle [Bernstein et al. 1987; 
Bernstein et al. 2002; Allen 2006; Parikka 2008A; Toivonen 2008].
A bradycardia pacemaker consists of a power generator with one or 
more electrode leads attached to it. The metallic generator case (approx. 
20 g) contains a power source, usually a lithium-iodine battery, and a 
microprocessor which controls the pacing feature and can be programmed 
externally. It can also include a detector that adjusts the heart rate to 
comply with the patient’s state of physical effort (rate-adaptive pacemak-
ers) when the heart’s own rate adjuster does not work. The electrode leads 
are led to the heart trough one or more veins, and they pass the sensing 
information from the heart to the pacemaker and the pacing impulses 
from the pacemaker to the correct spot in the heart. The pacemaker 
generator is usually implanted to the right pectoral side of the body, 
underneath the collar bone. Sometimes it can also be implanted to the 
left pectoral side or very rarely in the abdomen [Allen 2006; Hartikainen 
2008; Toivonen 2008]. 
Bradycardia pacemakers can be programmed to operate as unipolar 
or as bipolar settings. A unipolar pacemaker has only one electrode tip 
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in the end of the lead which acts as a negative pole during the pacing 
and the generator case itself acts as an another electrode, the positive 
pole, or vice versa. A bipolar pacemaker has two electrode tips in the end 
of the lead, approximately 1–2 cm from each other [Toivonen 2008]. 
An implantable cardioverter-defibrillator (ICD) is used to treat life-
threatening ventricular arrhythmias when pharmaceutical treatment has 
proven to be insufficient. It is most often implanted in a patient who suffers 
from long term ventricular tachycardia (VT) or has survived ventricular 
fibrillation (VF). ICD-treatment has become more common also in the 
treatment of other heart diseases which contains a risk of sudden death, 
such as coronary artery disease, heart failure, and inheritable arrhythmia 
and myocardial diseases. An ICD is often implanted in a patient who has 
been resuscitated from VT or VF because their recurrence probability 
without treatment is high. Approximately one in every four patients the 
ventricular arrhythmia experiences a recurrence during the next year [Hui-
kuri and Raatikainen 2008; Pakarinen and Toivonen 2010]. 
The function of the ICD is based on the sensing of the heart’s intrin-
sic rhythm and on the treatment of possible arrhythmias. The ICD can 
also act as a bradycardia pacemaker and treat bradycardia arrhythmias. 
When an ICD senses a dangerous tachyarrhythmia it starts to treat the 
heart with anti-tachycardia pacing (ATP). In ATP the ICD paces the 
heart at a rate higher than the intrinsic tachycardia rate. More than 90% 
of the common tachycardias stop with ATP treatment. If the heart rate 
does not change back to normal, the ICD gives a low energy (5–10 J) 
cardioversion shock to the heart, timing it to comply with the heart’s 
own rate. When it is not possible to time the shock with the ventricle’s 
contraction, the ICD gives the heart high energy (28–42 J) defibrillation 
therapy. Defibrillation is used to treat VF and high rate VT. More than 
95% of the VFs revert to sinus rhythm with ICD treatment; however, 
sometimes the ICD needs to defibrillate the heart several times. The ICD 
treatment increases the life expectancy of many patients and improves 
their quality of life. The risk of sudden death due to cardiac reasons 
decreases 50–60% with ICD teratment compared to pharmaceutical 
treatment. In addition, when used as preventative treatment of high 
risk patients, ICD treatment reduces the overall death rate with 20% 
when compared to pharmaceutical treatment [Allen 2006; Huikuri and 
Raatikainen 2008].
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Pacemakers can be complemented with a function to treat heart 
failure. These devices are called as biventricular pacemakers with cardiac 
resynchronizing therapy (CRT-P). They can also be combined with 
defibrillation to resynchronize the ICD (CRT-D). Biventricular pace-
makers are used to restore the beating force and synchrony of a heart 
that beats ineffectively. Heart failure is an outcome of a heart disease 
that has led to the failure of the heart muscle. The heart cannot pump 
enough blood to the body due to decrease in the left ventricle’s ability to 
contract. Disturbances in atrioventricular conductivity, in conductivity 
between the ventricles, and in conductivity inside the left ventricle are 
common. Biventricular pacemaker treatment enhances quality of life and 
the physical capacity of patients with severe heart failure. Biventricular 
pacemaker treatment has been estimated to reduce the secondary end 
point death rate from any cause of heart failure patients by 24–36% and 
their death rate due to heart failure by 34–40% [Bristow et al. 2004; 
Pakarinen 2008; Parikka 2008B; Pakarinen and Toivonen 2010].
Electromagnetic interference with pacemakers/ICDs
Electromagnetic interference with a pacemaker/ICD caused by external 
EMFs is usually temporary, and the device returns to its normal operation 
after the field disappears. However, contact currents, electric shocks and 
strong magnetic fields, such as those emitted by MRI equipment, can 
permanently harm or even terminate the pacemaker’s/ICD’s operation. 
The occurrence of EMI in device function is affected by the character-
istics of the external field. In addition to the intensity of the field, also 
its frequency, waveform, modulation and direction contribute to the 
occurrence, type and severity of the possible EMI [Pinski and Trohman 
2002A; Sweesy et al. 2004; Hocking and Hansson Mild 2008].
Different pacemakers and ICDs react differently to external EMFs 
and all electric applications can be sources of EMI. However, modern 
pacemakers and ICDs are able to deal with most of the external EMFs in 
a way that they do not cause danger to the device itself or to its wearer. 
In addition, most of the electric devices emit EMFs that are too weak to 
affect the pacemaker/ICD function. However, every pacemaker and ICD 
should be considered individually when assessing its risk to experience 
EMI in different situations. Even pacemakers/ICDs with the same model 
and programmed settings can be affected differently. The pacemaker pa-
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tient’s dependency on the pacemaker and his/her heart illness as well as the 
pacemaker/ICD model and settings define the severity and consequences 
of the interference. Modern pacemakers and ICDs have been found to be 
quite well shielded against external high frequency EMFs and the main 
concern is low frequency fields, especially low frequency magnetic fields.
The individually programmed parameters of pacemakers/ICDs affect 
their susceptibility to EMI. The sensitivity and polarity settings of the 
pacemaker are the main factors. The more sensitive the pacemaker is to 
the electric signals of the heart, the more sensitive it is also to external 
electromagnetic disturbances. It also interprets the external signals as 
arrhythmias more easily when programmed to low detection rates for 
arrhythmias [Pinski and Trohman 2002A; Sweesy et al. 2004].
Unipolar bradycardia pacemaker systems have been found to be more 
susceptible to external EMFs than bipolar pacemakers [Toivonen et al. 
1991; Wilke et al. 1998; Trigano et al. 2005B; Gwechenberger et al. 2006; 
Della Chiara et al. 2007]. In ICD devices the electrode leads are always 
bipolar. Interaction between the pacemaker and magnetic field can be 
caused by the loop, formed by the electrode parts of the lead, and the 
voltage induced between them. The area of the loop depends on the con-
figuration of the lead. A bipolar lead has two electrodes near each other 
(1–2 cm) inside the heart, forming a small loop between them, whereas 
in a unipolar system, the area formed between the two poles is much 
larger. In addition, the induction area of the unipolar system depends 
on the size of the person. Being of a large size increases the induction 
area and thus adds the possibility of EMI. The induction areas formed 
by the unipolar and the bipolar electrode leads when the pacemaker is 
implanted to the left pectoral side of the body are presented in Figure 
1. When the pacemaker is programmed to unipolar sensing settings, the 
site of the implantation is quite important. The induction area is much 
larger when a unipolar pacemaker is implanted to the left pectoral side 
instead of the right side. The induction areas of a unipolar pacemaker are 
presented in Figure 2. In addition, external magnetic fields can induce 
currents into the tissue around the pacemaker/ICD and hence lead to 
occurrence of EMI [Shah and Ellenbogen 2001; Irnich 2002; Irnich and 
Bernstein 2006; Della Chiara et al. 2007].
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Figure 1. The induction areas formed by the electrodes of the unipolar and the 
bipolar systems, simulating implanted pacemakers on the left pectoral side. 
Figure 2. Different induction areas for unipolar systems when implanted on 
right or left pectoral side.
According to European Standard EN 50527-1 which is based on the 
General Public Reference level of the EU Council Recommendation 
(1999/519/EC), a magnetic flux density of 100 µT is considered the 
‘safety-level’ for pacemakers and ICDs at 50 Hz [The Council of the 
European Union 1999; CENELEC 2010]. This level meets the 1998 
ICNIRP reference level for general public exposure to 50 Hz magnetic 
fields and complies with pacemaker manufacturers’ recommendations 
for pacemaker/ICD exposure limits [ICNIRP 1998; Boston Scientific, 
Medtronic, St. Jude Medical 2012].
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EMI in pacemakers and ICDs can be mainly divided into malfunc-
tions in either the sensing or pacing features. Other malfunctions, such as 
heating of the electrodes due to exposure to strong RF fields or complete 
electrical reset of the device, are rarer. Possible malfunctions to pacemaker/
ICD function due to EMI are listed below [Shah and Ellenbogen 2001; 
Luechinger et al. 2002; Pinski and Trohman 2002A; Rasmussen et al. 
2002; Hauser and Kallinen 2004; Kolb et al. 2004; Sweesy et al. 2004].
•	 Reversion to noise mode
 This is a common response of a pacemaker/ICD to external EMFs. 
It results from algorithms in the microprocessor of the device, 
designed to protect its function. Reversion to noise mode usually 
leads to asynchronous pacing, depending on the settings of device 
manufacturer. Its purpose is to prevent inappropriate inhibition of 
pacemaker output from sensed noise. The noise mode can be pro-
grammed individually beforehand and the pacemaker/ICD usually 
returns to its normal mode when the external field disappears.
•	 Pacing inhibition, e.g., complete or intermittent loss of pacing
 The pacemaker interprets an external signal as intrinsic heart activity 
(oversensing) and stops the pacing, even in the absence of any int-
rinsic rhythm. Long-term malfunctions of complete loss of pacing 
are rare because of the protecting algorithms of the pacemaker but 
short term malfunctions are common. 
•	 Triggering of fast or premature pacing
 Atrial oversensing of a dual-chamber pacemaker or ICD can trigger 
ventricular pacing at (or near) the upper tracking limit. Alternative-
ly, automatic mode switching (AMS) can occur if it is enabled. The 
most common automatically swithed mode is ventricular pacing. 
Atrial or ventricular pacing during inappropriate AMS can lead 
to asynchronous atrial pacing in DDI mode and asynchronous 
ventricular pacing in VVI mode, respectively. It can also lead, 
though very rarely, to arrhythmias and pacemaker syndrome. In 
some pacemakers, triggering of the noise reversion mode is also 
possible. More rarely, EMI can induce rapid pacing via some other 
mechanisms.
27
1 introduction
•	 False arrhythmia detection in ICDs
 The ICD interprets external signal as ventricular tachycardia (VT) 
or -fibrillation (VF) and treats it with ATP or by giving a high 
voltage therapy shock.
•	 Activation of the magnetic switch
 The magnetic switch (Reed switch) of a pacemaker or an ICD 
usually closes when external static magnetic field reaches 1–3 
mT and induces temporary asynchronous pacing. It blocks the 
interpretation and treatment of tachyarrhythmias in most ICDs. 
Normal operation usually returns after the magnetic field disap-
pears. However, in some ICD models, after few tens of seconds, the 
magnetic switch stays closed until reprogramming of the device. 
Many new devices have an alarm sound to indicate that the switch 
is closed or the function is inhibited. 
•	 Electric reset
 Strong external interference can induce a high voltage peak into 
the pacemaker/ICD electrode lead system and cause a transition 
to reset mode. In reset mode, the pacemaker functions only with 
basic factory preset settings. The reset mode does not convert back 
when EMFs disappear and reprogramming of the device is needed 
to restore its normal function.
•	 Dangerous heating of the electrode tips
 Heating of the electrode tips can cause burns to the electrode-tissue 
junction which can increase the pacing threshold and render the 
pacemaker unable to pace the heart. This is a very rare malfunction 
but it can happen due to strong RF-fields such as used in MRI.
•	 Damage to the electric components
 Permanent damage of the pacemaker/ICD due to strong EMI can 
affect its function and even terminate it, leading to replacement of 
the device. However, this kind of damage is very rare.
•	 External signal is interpreted as a programming signal
 Very rarely an external signal can be interpreted as a programming 
signal, leading to reprogramming of the device.
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Another type of EMI with pacemakers and ICDs is telemetry interfer-
ence. EMFs can be interpreted as monitoring or programming telemetry 
signals and thus effect the telemetry process. Telemetry interference can 
be clinically significant, especially because pacemaker/ICD treatment is 
moving toward remote monitoring and programming [Thaker et al. 2008].
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2  lITERATuRE REvIEW
This literature review focuses on experimental studies and case reports 
presenting results that show electromagnetic interference with pacemakers/
ICDs, ruling out temporary interference with device programming telem-
etry and EMI from ionizing radiation. In addition, the articles considered 
here have been published mainly during the past 15 years. Older reports 
were discarded due to developed techniques of the pacemakers and ICDs. 
In this literature review, the Pubmed database was used to track suit-
able publications concerning pacemaker/ICD EMI. For some sources of 
EMI, such as MRI, great amounts of publications were found and only 
some of them could be included to this review due to its limited size.
2.1  In vitro laboratory studies using    
 Helmholtz coil
This chapter reviews in vitro studies conducted in laboratory settings 
using a Helmholtz coil to generate magnetic fields and a body phantom 
to simulate real implantation of a pacemaker or an ICD. In vitro and in 
vivo studies on EMI from real-life electric devices and applications are 
reviewed in Chapter 2.3. In addition, this chapter describes different 
simulators of human body and tissues used in in vitro studies on EMI 
in pacemakers/ICDs. 
The in vitro tests reviewed here are real experimental studies on pace-
maker/ICD EMI using Helmholtz coil systems. Articles mainly present-
ing new test protocols or their validation were excluded from the review. 
Also studies where EMI test signals were applied to the pacemaker/ICD 
input were excluded. 
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Only one of this kind of in vitro interference study using Helmholtz 
coils to produce magnetic fields in laboratory settings was found. Della 
Chiara et al. investigated one pacemaker with different programmed 
modes and settings using sinusoidal, 50 Hz magnetic fields up to 2 mT. 
In addition, the tests were repeated with three different pulsed fields us-
ing the sinusoidal frequency of 50 Hz. With continuous waves, standard 
asynchorous pacing was observed with a minimum magnetic flux density 
of 42 µT when atrium (sensing and pacing) and ventricle (only pacing) 
were unipolar. When atrial sensing was bipolar and pacing unipolar with 
unipolar ventricle, irregular asynchronous pacing was observed with a 
minimum field of 950 µT. With pulsed waves and totally unipolar set-
tings, atrial tracking, where a falsely sensed atrial signal drives ventricle 
pacing, was observed at a minimum field of 13 µT. Random inhibition 
of the pacemaker was observed at a minimum of 11 µT, and complete 
inhibition at a minimum of 38 µT. With pulsed waves and bipolar atrium 
and unipolar ventricle, complete pacemaker inhibition and random or 
standard asynchronous pacing was observed with a minimum magnetic 
flux density of 35 µT [Della Chiara et al. 2007].
Several phantoms or body simulators, in which a pacemaker/ICD 
has been immersed in saline or gelatin during EMI tests, have been de-
scribed in the literature. One of them has been used in in vitro tests using 
Helmholtz coils, mentioned above. Some of the simulators described here 
have been presented in studies that are not reviewed in this literature 
review. For example, an electrically inactive, real size, whole body model 
was presented by Gustrau et al. [Gustrau et al.2002]. A similar whole 
body mannequin was used by Korpinen et al. [Korpinen et al. 2012]. 
An electrically passive, real size, torso phantom was used by Gwechen-
berger et al. [Gwechenberger et al. 2006]. Different size human trunk 
simulators, for example, cylindrical and cubical tanks with or without 
heartbeat simulators have also been used [Bassen et al. 1998; Miller et 
al. 1998; Wilke et al 1998; Barbaro et al. 1999; Tri et al. 2004; Kainz et 
al. 2005; Irnich and Bernstein 2006; Brand et al. 2007; Dubner et al. 
2007; Bassen 2008; Seidman et al. 2010; Gomez et al. 2013; Weyer et al. 
2012]. More complex phantoms with chambers simulating atriums and 
ventricles of the heart, as well as physiological, electrical and anatomical 
features of the heart using heartbeat simulators, have been introduced 
[Angeloni et al. 2003; Fukuta et al. 2005; Della Chiara et al. 2007]. In 
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addition, some in vitro tests were conducted in air, without a phantom 
[Garofalo et al. 2002; Kainz et al. 2005; Jilek et al. 2010].
2.2  In vivo laboratory studies using    
 Helmholtz coil
In vivo EMI studies conducted in laboratory settings using Helmholtz 
coil to produce magnetic fields are reviewed in this chapter. Only two 
studies could be found. 
Trigano et al. performed 250 tests to 245 pacemaker patients using 
50 Hz magnetic fields with a maximum flux density of 100 µT. EMI 
was observed in four of the 250 tests. A mode switch occurred with 
three of the pacemakers tested as unipolar settings leading to transient 
asynchronous pacing in two pacemakers and to pacing inhibition result-
ing in complete atrioventricular block in one of the pacemakers. With 
the fourth interfered pacemaker (bipolar) transient ventricular pacing 
with a shorter than programmed atrioventricular delay was observed 
[Trigano et al. 2005B]. 
The other in vivo study utilizing Helmholtz coil was published by 
Frank et al. Sixty pacemaker patients were exposed to 50 µT magnetic 
fields with frequencies of 50 Hz and 60 Hz. All of the pacemakers were 
reprogrammed to unipolar settings and highest sensitivities that did not 
induce muscular inhibition while moving. Transient reversion to noise 
mode was observed in six, transient acceleration due to atrial detection 
of interference in three, and T wave detection by the ventricular lead in 
one of the pacemakers tested [Frank et al. 2003].
2.3  studies with real sources of EMFs
2.3.1  non-medical environment
In this chapter, studies on real-life sources of EMFs that have been found 
to cause EMI with pacemakers and ICDs are reviewed. 
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Electronic article surveillance (EAs) systems
Electronic article surveillance (EAS) systems are used for example in 
stores, museums, and libraries to prevent thefts. They are commonly 
walkthrough gates that are installed in the vicinity of cash desks or exits 
of the stores. The gates usually involve coils that generate a magnetic 
field and a field receiving component that detects magnetic tags brought 
to the field. EAS systems can be in four frequency ranges: 1) non-linear 
magnetic (10 Hz–20 kHz, continuous wave at specific frequency), 2) 
resonant inductive or acoustomagnetic (20–235 kHz, pulses at specific 
frequency), 3) resonant radio frequency (1–20 MHz, sweeps through a 
frequency band), and 4) non-linear microwave (0.8–2.5 GHz, pulsating 
waves) [ICNIRP and WHO 1999; Bolte and Pruppers 2006].
Mugica et al. investigated 204 pacemaker patients with an acousto-
magnetic and a magnetic audio frequency EAS system, emitting inter-
mittent 58 kHz and continuous 73 Hz signals. EMI occurred with 17% 
of the pacemakers, with both unipolar and bipolar lead configurations, 
appearing in false under- and oversensing, and mode disruptions. Over 
twice as many malfunctions occurred with the acoustomagnetic system 
as with the magnetic audio frequency system [Mugica et al. 2000]. 
Similarly, in a study by McIvor et al, 50 pacemaker patients were tested 
with two magnetic audio frequency, three swept radiofrequency, and one 
acoustomagnetic EAS systems. One magnetic audio frequency system 
interfered with 4%, the swept radiofrequency systems with 0%, and the 
acoustomagnetic system with 96% of the unipolar and bipolar pace-
makers tested. Detected malfunctions were asynchronous pacing, atrial 
and ventricular oversensing leading to ventricular tachycardia detection 
and pacing inhibition and EMI induced pacing [McIvor et al. 1998]. 
However, Wilke et al. tested 53 pacemakers (unipolar and bipolar) in 
vivo and nine pacemakers (all unipolar) in vitro with antitheft device 
transmitting pulsed 120 kHz magnetic fields. They found no EMI with 
the pacemakers tested in vivo but pacemaker inhibition with all the 
pacemakers tested in vitro [Wilke et al. 1998]. In addition, Groh et al. 
investigated EAS systems and ICDs by testing 169 ICD patients with 
one pulsed acoustomagnetic system and two different electromagnetic 
systems. Three of the 169 ICDs tested with acoustomagnetic systems 
showed inappropriate tachyarrhythmia detection likely to result in ICD 
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therapy shocks. Some 126 of the ICDs were also tested with pacing fea-
ture on and 19 experienced EMI. Seven of them experienced a clinically 
relevant malfunction: oversensing leading to intermittent or complete loss 
of pacing. These malfunctions occurred with five of the ICDs when they 
were tested with the acoustomagnetic system and with two of the ICDs 
while tested with one of the electromagnetic systems [Groh et al. 1999].
Induction hobs
Induction hobs are commonly used in modern households and industrial 
kitchens. The operation of an induction hob is based on the magnetic 
field induced energy to a metallic pan on the plate. An induction coil 
under the ceramic surface of the hob generates magnetic field, which 
induces eddy currents to the pan leading to generate heat. The operation 
frequencies of the induction hobs are in the range of 20–50 kHz, with 
powers of some kilowatts [ICNIRP and WHO 1999].
Frank et al. tested 60 patients with a unipolar, dual chamber pace-
maker using an induction hob operating with frequencies from 20 kHz 
to 50 kHz. They found EMI with one pacemaker which shifted out 
of its special programme during the tests, but maintained its standard 
programme [Frank et al. 2003]. Hirose et al. used four different kinds 
of unipolar pacemakers to perform in vitro inhibition and asynchronous 
pacing tests near an induction oven operating with frequencies of 25 
kHz and 34 kHz. 32 cm was found to be the maximum distance above 
the induction hob up to which pacemaker inhibition occurred. The 
maximum distance above the hob up to which asynchronization occurred 
was found to be 34 cm [Hirose et al. 2005].
Welding equipment
Welding is a technique to join metal pieces together by heating the metal 
and bringing the components together. In addition to gas and laser 
welding, several types of electric welding processes are used in different 
industry sections: arc welding (for example MIG), resistance welding, 
high frequency resistance welding, and electron beam welding. Arc weld-
ing involves striking an electric arc between an electrode and a workpiece 
to melt the materials to be joined using direct, pulsating direct, and 
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alternating current. The AC frequency is usually the mains frequency of 
50 Hz but higher frequencies can also be used. The electric current used 
in arc welding varies from 50 A to 1 kA depending on the process and 
the metal. Resistance welding uses short periods of current across the gap 
between the two components pressed firmly together. High frequency 
resistance welding does not use mains frequency but frequencies above 
100 kHz. In addition, the electron beam welding process uses EMFs to 
heat the metal with an electron gun in vacuum and is, thus, mechanized 
[Hietanen et al. 2002; Bolte and Pruppers 2006].
No scientific studies on pacemaker/ICD EMI during electric weld-
ing could be found from the literature published over the past 15 years. 
However, electric and especially arc welding can be considered a potential 
source of clinically significant EMI with pacemaker and ICD function.
Mobile phones and base stations
Wireless telecommunication contains signal transmission between mo-
bile telephones and fixed base stations. Old, analogue mobile phones 
(for example, Nordic Mobile Telephone (NMT)) transmit continuous 
frequency-modulated sinusoidal carrier signal having the same maxi-
mum and average powers. Studies about analogue mobile phones are 
left out of this literature survey due to their outdated results. At present, 
the most commonly used mobile phones are digital systems based on 
the harmonized Global System for Mobile Communications (GSM) 
transmitting pulsed signals consisting of short carrier wave bursts. GSM 
phones operate at frequencies of 900 and 1 800 MHz with the maximum 
peak power of its output signal 2 W (for 900 MHz) and 1 W (for 1 800 
MHz) and the maximum time-average power of 1/8 of the peak power. 
Other common digital systems include the Terrestrial Trunked Radio 
(TETRA) used by the police and other emergency personnel. TETRA 
operates at around 400 MHz and its maximum peak power output is 
30 W. The Universal Mobile Telecommunication System (UMTS), the 
third generation mobile communication system, operates at frequencies 
of 1 900–2 200 MHz [Hietanen et al 2002].
Mobile phones have been a fairly common source of EMI with older 
pacemaker models [Altamura et al. 1997; Hayes et al. 1997; Bassen et 
al. 1998; Barbaro et al. 1999]. Altamura et al. found pacemaker interfer-
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ence in 21.5% of 200 in vivo tested, mostly unipolar pacemakers, when 
exposed to GSM mobile phones. Some 18% of the pacemakers tested 
experienced inhibition, 5.4% of the 72 pacemakers in which it was pos-
sible to perform mode switch test switched into asynchronous pacing 
mode, 9.4% of the 74 pacemakers with DDD/VDD mode experienced 
synchronization by EMI [Altamura et al. 1997]. Hayes et al. studied 
GSM EMI with 980 pacemaker patients and reported the incidence of 
interference to be 23.7%. Both unipolar and bipolar pacemakers were 
reported to experience tracking interference sensed on the atrial channel, 
noise reversion or asynchronous pacing, and ventricular inhibition as the 
most common types of EMI. In addition, atrial inhibition, ventricular 
safety pacing, undersensing, and rate-adaptive sensor-driven pacing were 
also seen, although, less commonly [Hayes et al. 1997]. EMI between 
digital mobile phones and ICDs was tested in vitro by Bassen et al. 
Three ICDs were tested with two phones and all of them experienced 
pacing inhibition with one or two of the phones leading in three out 
of four cases to inappropriate ICD shock [Bassen et al. 1998]. In ad-
dition, Barbaro et al. tested ICDs with GSM phones both in vitro and 
in vivo. Four out of six ICDs tested in vitro in air experienced pacing 
inhibition, electrical reset, and false VT and VF detection. No EMI was 
observed during the in vitro tests in saline. During the in vivo tests, three 
out of 13 pacemakers tested, all of the same model and in DDD mode 
showed ventricular triggering with the interfering signal at the upper 
rate [Barbaro et al. 1999]. 
Newer pacemaker and ICD models are more resistant to RF EMFs 
and thus interference from digital mobile phones does not pose a great 
risk today [Chiladakis et al. 2001; Elshershari et al. 2002; Tandogan et 
al. 2005A; Ismail et al. 2010]. Some reports about the mobile phone 
EMI particularly with unipolar pacemakers, but also with bipolar de-
vices, can, however, be found after the year 2000 [Hekmat et al. 2004; 
Tandogan et al. 2005B; Trigano et al. 2005A]. Hekmat et al. found two 
out of 100 pacemakers tested in vivo to experience pacing inhibition with 
a GSM mobile phone. The same effects were seen with both unipolar 
and bipolar lead configuration [Hekmat et al. 2004]. Tandogan et al. 
tested 679 pacemaker patients using both unipolar and bipolar lead po-
larity with every pacemaker tested. Of the pacemakers tested 5.5% were 
adversely affected showing malfunctions of conversion to asynchronous 
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mode, inhibition, and ventricular triggering. When the lead polarity 
was unipolar, the rate of malfunctions was higher and the effects more 
significant when compared to the bipolar configuration [Tandogan et 
al. 2005B]. Trigano et al. found oversensing leading to irregular and 
rapid ventricular pacing or to transient, inappropriate safety pacing in 
four out of 330 tests performed on 158 pacemaker patients with digital 
mobile phones and pacing inhibition leading to presyncope in one of 
the tests. All but one of the malfunctioned pacemakers had a bipolar 
lead configuration [Trigano et al. 2005A].
Most of the adverse effects found in pacemaker/ICD function caused 
by exposure to the RF EMFs of digital cellular phones have occurred 
while the phone has been positioned directly above the pacemaker/ICD 
or at a short distance from it.
The operation of mobile phones is based on the radio signal transfer 
between the phone and antennas of a base station. Mobile phones are 
connected to the nearest base station by two separate radio links: the 
uplink from the phone to the base station transmitting speech of the 
caller, and the downlink from the base station to the phone transmitting 
speech of the respondent. The coverage cell of a base station is ideally 
hexagonal and ranges from 1 to 35 km, but can vary in size. It contains 
several transmitters, whose outputs are combined and fed to the anten-
nas. The typical output power of a single transmitter is between 10 and 
40 W. The base station antennas are normally located in towers and on 
the roofs and ceilings of buildings [Hietanen et al. 2002].
Mobile phone base stations have not been reported to cause EMI 
with pacemakers or ICDs. However, because the EMFs emitted by base 
stations are similar to those emitted by mobile phones, it is possible that 
they can also interfere with pacemaker function [Alanko et al. 2008, 
Toivonen et al. 2009]. This may happen in some specific situations when 
a pacemaker is in the close vicinity of a base station antenna, for instance 
when a maintenance worker with a pacemaker installs or maintains the 
antenna with his/her chest close to an active transmitter.
Electric trains
In most of the European countries, 50 Hz is the operating frequency used 
by electric trains with AC overhead voltage supply between 10 and 30 
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kV. The magnetic fields inside the cabins vary greatly due to variations 
in the speed and the load carried by the train [Hietanen et al. 2002]. No 
published reports were found about possible EMI with pacemakers in 
electric trains. However, one study has been published about the risk of 
EMI with implanted arrhythmia devices in magnetically levitated linear 
motor car train. No interference either with pacemakers or with ICDs 
was observed in the study [Fukuta et al. 2005].
High voltage transmission lines
High voltage transmission lines produce quite high electric and mag-
netic fields in the surrounding area and below the lines. Under 400 kV 
power lines, the magnetic flux density is 10–15 µT and the electric field 
strength 6–10 kV/m. The corresponding values under 765 kV lines are 
30–40 µT and 10–12 kV/m. EMFs generally decrease to background 
strengths at distances of 50 to 100 m, depending on the line design and 
current [Hietanen et al. 2002].
EMFs emitted by overhead power lines have been reported to cause 
EMI with pacemakers. Korpinen et al. tested in vitro 31 unipolar pace-
makers under 400 kV power lines. In addition, 11 of the pacemakers 
were also tested with bipolar lead configuration. During the tests, one 
pacemaker experienced atrial high rate episode when programmed with 
unipolar settings. Minor disturbances were also seen in a few other pace-
makers tested [Korpinen et al. 2012]. 
Permanent magnets
Devices that contain permanent magnets emit static magnetic fields (0 
Hz). Static magnetic fields produced by, for example, headphones, and 
small neodymium magnets have been shown to cause EMI with pacemak-
ers and ICDs [Wolber et al. 2007; Ryf et al. 2008; Lee et al. 2009]. EMI 
can occur when the magnetic switch of a pacemaker or an ICD is affected 
by a static magnetic field. In pacemakers and ICDs, Reed switches are 
typically closed by 1.0–3.0 mT magnetic fields and reopen at 0.7–1.0 
mT, depending on the device model [Luechinger et al. 2002; Kolb et al. 
2004]. In recent years, Hall sensors and semiconductor magnetic switches 
are more and more used. In them, opening and closure of the switch oc-
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cur at the same field strengths. The closure of a magnet switch results in 
temporary asynchronous pacing in pacemakers. In most ICDs it results in 
temporary suspension of tachyarrhythmia detection, leaving bradycardia 
pacing function unaffected [Wolber et al. 2007]. However, although usually 
the ICD conversion to magnet mode due to static magnetic field is only 
a temporary effect, the effects can be permanent in some makes of ICDs. 
With certain programming in some ICD models, arrhythmia detection 
and therapy can be permanently deactivated in 30 seconds by a magnet 
[Rasmussen et al. 2002; Hauser and Kallinen 2004]. 
Wolber et al. tested 41 pacemaker patients and 29 ICD patients with 
two spherical magnets: a necklace made of 45 spherical magnets, and a 
magnetic name tag all made from neodymium-iron-boron. EMI was ob-
served in all the pacemakers and ICDs tested. The maximum distance at 
which EMI occurred was 3 cm [Wolber et al. 2007]. Ryf et al. investigated 
one sample pacemaker in vitro with different kinds of magnets made from 
the same compounds with nickel coating, one levitation toy magnet, and 
one conventional ferrite office magnet. Pacemaker function was found 
to suffer interference at distances from 1 cm to 24 cm depending on the 
magnet tested [Ryf et al. 2008]. Portable headphones were found to induce 
clinically significant EMI in pacemakers and ICDs in a study by Lee et al. 
Some 45 patients with a pacemaker and 55 with an ICD were tested with 
eight different portable headphones resulting in clinically significant EMI 
observed in 9/45 of the pacemakers and 21/55 of the ICDs. The most 
common effect was magnet response characterized in all nine pacemakers 
by asynchronous pacing and in ICDs by audible sounding of the magnet 
alarm and inhibition of tachyarrhythmia detection [Lee et al. 2009].
other non-medical sources of EMI: digital media players, Metal 
detectors, and  Radiofrequency identification (RFId) systems
Several other kinds of electric devices have also been studied and found 
to cause EMI with pacemakers and ICDs. Digital media players are a 
format for portable music and are commonly carried in a shirt pocket. 
Thaker et al. tested four types of media players with 100 pacemaker 
patients and found that 19% of the pacemakers tested experienced inter-
ference during the tests, regardless of their lead configuration (unipolar 
vs. bipolar) [Thaker et al. 2008]. 
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Handheld and walk-through metal detectors are used in security 
applications at, for example, airports and official buildings. Metal detec-
tors sense disturbances in magnetic field when a metallic object enters 
its detection zone. The transmitted field creates an eddy-current in the 
metallic object that generates an opposing field [Bolte and Pruppers 
2006]. Walk-trough detectors operate with continuous sinusoidal sig-
nals at one or more frequencies (630 Hz–7.375 kHz) or with pulsating 
signals at low-frequencies (89–909 Hz) and handheld detectors usually 
with unmodulated sinusoidal signals of 13 kHz–1.9 MHz [ICNIRP 
2004]. Kainz et al. tested in vitro a security system simulator with four 
unipolar pacemakers and compared the results with tests using two 
actual walk through metal detectors. Both, the simulator and the actual 
detectors were observed to cause EMI with the pacemakers resulting in 
partial atrial and intermittent ventricular inhibition, as well as full atrial 
inhibition and ventricular pulse tracking [Kainz et al. 2005]. 
Radiofrequency identification (RFID) systems are used to locate, 
identify, and track objects. They consist of transponder tags and an inter-
rogator reader. Tags can be inserted in or attached to products like cards, 
badges, or labels and readers read and write information to them. Readers 
range from large portal antennas, to desktop pad workstations, and to 
small handheld portable readers. RFID systems operate at many different 
frequencies: low-frequency RFID (125–135 kHz), high-frequency RFID 
(13.56 MHz), active 433 MHz RFID, ultra high-frequency (915 MHz) 
RFID, and microwave (2.45 GHz) RFID [ICNIRP 2004; Seidman 
et al. 2010]. Seidman et al. reported significant malfunctions in both 
pacemakers and ICDs when exposed to EMFs emitted by passive RFID 
systems. Some 67% of the 15 pacemakers tested in vitro experienced 
interference at a maximum distance of 60 cm from low frequency (134 
kHz) RFID and 6% of them at a maximum distance of 22.5 cm from 
high frequency (13.56 MHz) RFID. Respectively, 47% of the 15 ICDs 
tested in vitro experienced EMI at a maximum distance of 40 cm from 
low frequency RFID and 1% at a maximum distance of 7.5 cm from 
high frequency RFID [Seidman et al. 2010]. 
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2.3.2  Medical environment
Medical environments are among the most likely places for EMI to 
occur with pacemakers and ICDs. However, patients with a pacemaker 
or ICD may also require treatment and diagnostics with devices that 
introduce strong electric currents inside the body or emit high-intensity 
electromagnetic fields. Some of the most common sources of EMI in 
medical settings are presented in this chapter.
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a widely used technology for di-
agnostics as it provides great advantages in soft-tissue imaging compared 
to other available imaging systems. It poses, however, hazards to patients 
with a pacemaker or an ICD [Pinski and Trohman 2002B; Nair and 
Roguin 2005; Götte et al. 2010]. MRI uses static magnetic fields that 
cause attractive forces on ferromagnetic components, radiofrequency 
fields (10–100 MHz) that can cause heat damage, and gradient magnetic 
fields that can induce electrical currents in the pacemaker/ICD [Hietanen 
et al. 2002; Roguin et al. 2008]. In addition, combination of these fields 
can alter the function of pacemakers/ICDs and cause electrical reset or 
damage to the device or to its leads [Roguin et al. 2008]. 
Several studies have reported problems in pacemaker/ICD function 
during MRI scans and not all of them could be reviewed here. For exam-
ple, Heatlie and Pennell presented five patients with a bipolar pacemaker 
undergoing six cardiovascular MRI scans using a 0.5 T scanner. In one 
case, the pacemaker began pacing at maximum tracking rate [Heatlie and 
Pennell 2007]. In a study of Naehle et al., 18 patients with an ICD un-
derwent an MRI examination with a 1.5 T scanner. In two of the ICDs, 
oversensing of RF noise as VF was detected. A statistically significant 
decrease in battery voltage after the scans was observed in 16 of the ICDs 
tested (no data was available for two ICDs). Later follow up showed a 
full recovery of battery voltage after 4 of 16 MRI examinations [Naehle 
et al. 2009]. Gimbel et al. studied seven ICD patients undergoing eight 
MRI scans at 1.5 T. One of the ICDs tested experienced a power reset 
during a lumbar spine scan [Gimbel et al. 2005]. 
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The U.S. Food and Drug Administration (FDA) database reports 
several deaths associated with MRI scans of patients with a pacemaker in 
the 1980s and 90s [CDRH Working group 1997]. In addition, Martin 
and Sandler reported at least 17 supposed MRI associated deaths world-
wide among patients with pacemakers by 2007 [Martin and Sandler 
2007]. However, ‘MRI-safe’ pacemakers and ICDs are being developed 
and tested [Sutton et al. 2008; Forleo 2010; Jung et al. 2011; Wilkoff et 
al. 2011]. With appropriate precautions and careful monitoring, MRI 
can be considered to be relatively safe to patients who are not pacemaker 
dependent [Gimbel et al. 2005; Gimbel 2008; Roguin 2008; Naehle et 
al. 2009; Naehle et al. 2011; Zikria et al. 2011].
Electrocautery
Electrocautery is an electrosurgical technique that promotes hemostasis 
by heating a metal instrument without any current passed in the body 
[Pinski and Trohman 2002B]. The term ‘electrocautery’ can also be used 
when referring to electrosurgery. With this definition it uses a knife to 
cut and coagulate tissue with radiofrequency current. The generated RF 
currents can be interpreted by a pacemaker or ICD as an intracardiac 
signal. Electrocautery can also deliver a large amount of energy to the 
body, which can damage the pacemaker circuitry or myocardium at the 
pacemaker electrode-tissue interface [Shah and Ellenbogen 2001; Yerra 
and Reddy 2007; Dyrda and Khairy 2008]. At least one study after the 
year 2000 has reported minor EMI with pacemakers and ICDs during 
electrocautery [Cheng et al. 2008]. Cheng et al. studied 57 ICD and 35 
pacemaker patients who underwent non-cardiac surgical or endoscopic 
electrocautery. As a result, minor changes in lead parameters were noted, 
in addition to, three cases (two pacemakers, one ICD) of atrial mode 
switch episodes, and two cases (both pacemakers) of inappropriate sens-
ing of ventricular noise [Cheng et al. 2008].
Electrical nerve and Muscle stimulation
Transcutaneous electrical nerve stimulation (TENS) is used to treat 
acute and chronic musculoskeletal pain. It is a noninvasive technique 
that consists of electrodes placed on the skin trough which rectangular 
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electric pulses are conducted to the body with a low frequency of 20–110 
Hz [Pinski and Trohman 2002B]. 
Studies on TENS treatment have reported cases of inhibition of 
pacemaker function as well as sensing of inappropriate arrhythmias by 
ICDs [Holmgren et al. 2008; Carlson et al. 2009]. In a study by Carlson 
et al, 27 patients with a unipolar or bipolar pacemaker were tested us-
ing TENS. Of the pacemakers tested 81% experienced EMI resulting 
in inhibition of one or more pacemaker signal [Carlson et al. 2009]. 
Holmgren et al. tested 30 ICD patients with TENS treatment. Some 
27% of the ICDs experienced false VT/VF interpretations, 47% had 
premature ventricular extra beats, and 16% experienced others kinds of 
interactions: interpretations as noise, undersensing, and loss of telemetry 
connection [Holmgren et al. 2008]. 
Cronin et al. studied 2 and 50 Hz repetitive nerve stimulation (RNS) 
in 10 patients with an ICD and four with a pacemaker. In two subjects 
with an ICD, EMI was observed as noise. Two of the four pacemakers 
were tested only with bipolar sensing configurations and two with bipolar 
and unipolar configurations. Three of the pacemakers were observed to 
experience EMI. Only one pacemaker with bipolar sensing experienced 
a slight increase in paced ventricular rate due to atrial oversensing. How-
ever, both of the unipolarly programmed pacemakers detected transient 
inhibition of ventricular pacing [Cronin et al. 2013].
Neuromuscular electric stimulation (NMES) is used to prevent atro-
phy of immobilized muscles, for example to maintain leg muscle strength 
in patients with severe heart failure. These patients with heart failure, 
however, often also have a cardiac ICD. Crevenna et al. subjected eight 
patients with an ICD to NMES of the neck and shoulder and to the 
thighs. Inappropriate ventricular sensing was observed in two of the ICDs 
tested during stimulation of the neck and in two during thigh stimula-
tion, and false atrial sensing was seen in two of the four dual chamber 
ICDs tested during stimulation of the neck [Crevenna et al. 2003]. 
Wireless capsule Endoscopy
Wireless video capsule endoscopy is a noninvasive diagnostic technique, 
which enables visualization of the mucosa of the intestine without ra-
diation or traditional endoscopy [Yerra and Reddy 2007]. The system 
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consists of a capsule that contains a camera, lights, antenna, power source, 
and a telemetry transmitter. The swallowed capsule transmits data at 
radio frequency to an external recorder [Dubner et al. 2007]. This signal 
can, according to some studies, potentially interfere with pacemaker/
ICD function [Dubner et al. 2005; Dubner et al. 2007]. Dubner et al. 
observed reversion to noise mode forcing asynchronous behavior with 
four of the pacemakers of 100 patients tested during wireless endoscopy. 
All of the four pacemakers experiencing interference were programmed 
as bipolar sensing settings [Dubner et al. 2005]. The same group also 
tested ICDs, both in vitro and in vivo, during wireless endoscopy. One 
of six ICDs tested in vitro experienced oversensing and delivery of an 
inappropriate therapy, whereas all six ICDs tested in vivo showed no 
traces of EMI [Dubner et al. 2007].
left ventricular Assist devices
Left ventricular assist devices (LVADs) are cardiac assist devices that are 
used to treat heart failure as destination therapy or bridge to heart trans-
plantation. LVADs are mechanical pumps that take over the function 
of the damaged ventricle and restore normal hemodynamics and end-
organ blood flow [Goldstein et al. 1998]. Simultaneous use of LVADs 
and pacemakers/ICDs has triggered EMI between the devices [Foo et 
al. 2009; Oswald et al. 2009; Ambardekar et al. 2010]. 
Oswald et al. reviewed 46 ICDs implanted in LVAD recipients. Four 
of the 46 ICDs had to be replaced immediately after implantation of 
the LVAD due to complete and irreversible loss of telemetry between an 
ICD and a programming device [Oswald et al. 2009]. In a review of 15 
patients with a pacemaker or an ICD who subsequently had implanta-
tion of a LVAD by Foo et al., changes in lead parameters were observed 
after LVAD implantation: trend of decreased sensing of the intracardiac 
electrogram from the right ventricular (RV) lead, increase in RV lead 
stimulation thresholds, and changes in RV lead impedance. Three of 
the 15 patients had a significant increase in ventricular tachyarrhythmia 
episodes post-LVAD as compared to pre-LVAD. One ICD experienced 
ventricular oversensing leading to inappropriate defibrillation therapy 
[Foo et al. 2009]. Complying with these results, Ambardekar et al. studied 
31 ICD patients implanted with a LVAD and found significant post-
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LVAD changes in RV lead parameters: decrease in sensing amplitude and 
impedance, and increase in capture threshold [Ambardekar et al. 2010].
Radiofrequency catheter Ablation
Radiofrequency catheter ablation is used for treatment of supraventricular 
and ventricular arrhythmias. It produces 400–500 kHz signals between 
RF catheter tip and a large indifferent electrode usually placed on the 
patient’s thigh [Misiri et al. 2012]. 
In a study by Lakkireddy et al., of 86 patients that underwent RF 
ablation of atrial fibrillation, pacemaker atrial-lead dislodgement was 
noted in two patients [Lakkireddy et al. 2005]. Burke et al. investigated 
107 patients with pacemakers and defibrillator ventricular lead systems 
undergoing RF atrio-ventricular junction ablation and compared the 
effects of RF current on ventricular lead systems. Both the pacemaker 
and defibrillator leads (previously implanted or temporary) showed an 
increase in ventricular pacing voltage thresholds, many of them requiring 
device reprogramming or lead revision [Burke et al. 2001]. However, 
Sadoul et al. observed pacemaker inhibition, reset to backup mode, noise 
mode behavior, tachycardia detection, erratic behavior, oversensing, loss 
of ventricular capture, or increase in ventricular threshold in 53% of the 
38 (mainly unipolar) pacemakers tested during RF catheter ablation. 
Three devices resetting to backup mode required reprogramming to 
obtain normal operation [Sadoul et al. 1997].
Electric dental equipment
Electronic dental equipment items are sources of low-intensity EMFs 
and have been studied as possible sources of pacemaker/ICD EMI. 
Fourteen electric dental devices were tested in vitro for possible interfer-
ence with two pacemakers, one unipolar and one bipolar, by Miller et 
al. Atrial and ventricular pacing were inhibited in both pacemakers by 
EMI caused by an electrosurgical unit, an ultrasound bath cleaner, and 
two magnetorestrictive ultrasonic scalers [Miller et al. 1998]. Brand et al. 
tested in vitro ten different electrical dental devices with three ICDs. An 
ultrasound bath cleaner was found to cause false detection of ventricu-
lar noise in two of the ICDs tested [Brand et al. 2007]. Garofalo et al. 
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tested in vitro effects of five apex locators on the function of a unipolar 
pacemaker. One of the apex locators tested was observed to cause pac-
ing inhibition in the pacemaker [Garofalo et al. 2002]. Six electronic 
apex locators were tested, also in vitro, with one unipolar pacemaker by 
Gomez et al. One apex locator was found to cause EMI with the pace-
maker detected as false heart activity [Gomez et al. 2013]. Roedig et al. 
tested nine electronic dental devices in vitro with two pacemakers and 
two ICDs. EMI occurred with three of the devices: pacing inhibition was 
observed in both pacemakers and in one of the ICDs during operation 
of the battery-operated composite curing light, the use of the ultrasonic 
scaler interfered with the pacing of one of the pacemakers and both of 
the ICDs, and the operation of the ultrasonic cleaning system interfered 
with both of the pacemakers [Roedig et al. 2010].
other medical sources of EMI: lithotripsy, Magnetic drapes, 
Magnetic navigation systems, and Hyfrecators
Some other medical applications have also been observed to cause EMI 
with pacemakers/ICDs. Extracorporeal shock wave lithotripsy is used to 
noninvasively disintegrate urinary tract calculi and gall bladder stones 
[Dyrda and Khairy 2008]. During the treatment, the patient lies in a 
water bath and multiple hydraulic shocks are generated underwater and 
focused on the calculi by an ellipsoid metal reflector. Pacemakers and 
ICDs can be subject to EMI from the spark gap and mechanical damage 
from the hydraulic shock wave [Pinski and Trohman 2002B]. Electric 
reset of one ICD, out of four tested during shock wave lithotripsy treat-
ment was reported by Chung et al. [Chung et al. 1999]. 
Sterile magnetic drapes are used during surgery to hold metal instru-
ments on the sterile field. Zaphiratos et al. tested 50 pacemaker patients 
with a magnetic drape containing 70 removable magnets placed over the 
pacemakers. Asynchronous pacing due to activation of the magnetic switch 
the pacemakers was observed with 94% of the pacemakers, and in 54% of 
these pacemakers, EMI ceased when the drape was pulled 3 cm caudally 
and at 15 cm, no pacemaker experienced EMI [Zaphiratos et al. 2013]. 
A magnetic catheter navigation system, which is used for remote 
mapping and ablation, works with 80 mT static magnetic field and ap-
plies time-dependent field gradients. It allows remote directing of cath-
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eters and guide wires in the cardiovascular system. Jilek et al. tested 77 
pacemakers and 44 ICDs in vitro with one magnetic navigation system 
at its minimal magnet to magnet distance using a maximum of 0.1 T 
magnetic field. EMI was observed in six pacemakers tested resulting in 
reprogramming to a power-on-reset mode in five and abnormal variance 
of battery status in one pacemaker [Jilek et al. 2010].
Hyfrecators are commonly used in office based dermatologic surgery 
for hemostasis or destruction. A hyfrecator emits low-power high-
frequency current pulses to the patient through a hand held electrode 
[Weyer et al. 2012]. Weyer et al. tested three pacemakers and three ICDs 
in vitro by exposing them to EMFs of two common hyfrecator units. 
None of the ICDs tested were affected by the hyfrecators. However, atrial 
inhibition and full inhibition of pacing was observed in the pacemakers 
in very close proximity to the hyfrecators [Weyer et al. 2012].
2.4  case Reports
Numerous cases of EMI with pacemakers and ICDs have been reported. 
Reports include cases of device malfunction from incorrectly grounded 
electric devices and systems, radiated EMFs, and medical applications. 
Some other devices, such as Taser stun gun and arc welding equipment, 
have been reported to cause EMI in real life situations [Haegeli et al. 
2006; Trigano et al. 2006; Cao et al. 2007]. Energy delivery by a Taser 
stun gun was interpreted as VF by an ICD resulting in charging for 
VF therapy. The charged current, however, was diverted after the Taser 
energy delivery was finished [Haegeli et al. 2006]. Respectively, Cao et 
al. presented a report about high ventricular rate episodes stored in a 
bipolar pacemaker during an energy delivery by a Taser stun gun [Cao et 
al. 20074]. Trigano et al. reported a case of EMI with bipolar pacemaker 
by arc welding, stored as inappropriate atrial tachycardia leading to brief 
asynchronous ventricular pacing [Trigano et al. 2006].
Most of the published case reports describe situations where conduct-
ing an electric current through the body of a pacemaker/ICD wearer 
has triggered EMI. There are, however, a few reported cases of EMI 
resulting from radiated EMFs. For example, electric article surveillance 
(EAS) systems used in stores have caused inappropriate ventricular 
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tachyarrhythmia detection and therapy shocks with ICDs [Mathew et al 
1997; Santucci et al. 1998; Gimbel and Cox 2007; Koneru et al. 2011]. 
Gimbel and Cox also reported about loss of pacing in a single chamber 
pacemaker, and McIvor and Sridhar about rapid ventricular pacing due 
to atrial oversensing in a dual chamber pacemaker due to exposure to 
EMFs emitted by EAS systems [McIvor and Sridhar 1998; Gimbel and 
Cox 2007]. In addition, an induction heating rice cooker has been re-
ported to cause EMI with a bipolar pacemaker [Nagatomo et al. 2009]. 
Additionally, a reproducible oversensing case of a pacemaker with an 
iPod placed approximately 5 cm above it was reported by Patel et al. 
The pacemaker registered high atrial and ventricular rates regardless of 
the atrial and ventricular sensitivity and pacing mode polarity (unipolar 
vs. bipolar) [Patel et al. 2007]. In addition, unintentional ICD magnet 
mode switches due to magnets in a decorative brooch and inside jacket 
pockets have been reported [Li 2007; Beirnart et al. 2011].
Inappropriate ICD shocks due to current leaks from malfunctioning 
or insufficiently grounded electrical systems have been reported to occur 
in swimming pools and while taking a shower [Manolis et al. 2000; Garg 
et al. 2002; Lee et al. 2002; Fernengel et al. 2007; Pai et al. 2008; Spurrell 
et al. 2008]. Conducted currents due to wet hands or hands in the water 
have been reported to trigger ICD shocks also with a power drill, washing 
machine, and submersible fish pond pump [Vlay 2002; Chan and Ho 
2005]. Even a rare case of a lightning induced ICD shock while taking a 
shower has occured [Anderson et al. 2012]. Some cases have been reported 
about ICD shocks when touching a washing machine with dry hands 
[Sabaté et al. 2001; Kolb et al. 2002; Chongtham et al. 2007]. Other re-
ported cases about non-medical sources of current leaks that have caused 
EMI with ICDs are, for example, a household lamp, refrigerator, kitchen 
stove, sewing machine, radio alarm clock, hydro-massage bath, percussion 
drill, electric pruner, and electrically powered watering system [Kolb et al. 
2001; Al Khadra et al. 2006; Occhetta et al. 2006].
Several cases of EMI between medical applications and pacemak-
ers/ICDs have been reported. These reports are mainly focused on 
pacemaker/ICD malfunction due to conducted currents from surgical 
electrocautery as well as from electronic nerve and muscle stimulation. 
Electrocautery has been reported to induce inappropriate pacemaker 
rate responses resulting in rapid ventricular pacing or an abrupt onset 
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of bradycardia followed by brief asystole [Wong and Middleton 2001; 
Wilson et al. 2006; Abdelmalak et al. 2011]. Two reports introduce cases 
of complete pacemaker failure during electrocautery leading in one case 
to immediate asystole and in both cases to pacemaker replacement [Ner-
cessian et al. 1998; Peters and Gold 1998]. EMI during electrocautery 
has also caused false sensing of ventricular tachyarrhythmia by an ICD. 
However, therapy was averted because the interference noise stopped 
before the charging period of the ICD was finished. [Casavant et al. 
1998]. Transcutaneous electrical nerve stimulation has been reported 
to lead to inappropriate ICD shocks, and peripheral nerve stimulation 
has resulted in complete inhibition of a unipolar pacemaker [Philbin et 
al. 1998; Vlay 1998; Pyatt et al. 2003; Siu et al. 2005; Occhetta et al. 
2006; Engelhardt et al. 2007]. Inappropriate ICD shocks have also been 
received during electronic muscle stimulation treatments [Glotzer et al. 
1998; Kolb et al. 2001].
A magnetic catheter navigation system has been reported to induce 
EMI with a bipolar pacemaker, triggering an electrical reset of the pace-
maker and causing ineffective pacing [Kolb et al. 2007]. Implanted left 
ventricular assists, have been reported to cause complete failure to inter-
rogate an ICD, leading to its replacement or reimplantation [Cowger 
Matthews et al. 2007; Bakhtiary et al. 2008; Mehta et al. 2008]. Reddy et 
al. reported a similar case of total failure in interrogation of a pacemaker 
when implanted in a patient with a LVAD [Reddy et al. 2012]. Two 
separate cases of EMI induced ICD therapies immediately after LVAD 
placements have been published by Labedi et al. [Labedi et al. 2013].
Another source of pacemaker/ICD EMI with medical applications has 
been reported to be magnetic resonance imaging. A 0.5 T MRI caused 
the complete loss of ICD programmability and corrupted a major portion 
of the device memory leading to the need for ICD replacement [Fiek 
et al. 2004]. 1.5 T imaging has been reported to trigger a biventricular 
ICD to falsely detect ventricular fibrillation and 3 T imaging to trigger 
a bipolar pacemaker to revert to ‘back up mode’ causing pacemaker 
inhibition and asystole with a pacemaker dependent patient [Gimbel 
2009; McIntyre et al. 2010]. 
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3  AIMs oF THE sTudy 
Electromagnetic interference between electrical appliances and cardiac 
pacemakers/ICDs has been a challenge to researchers and physicians 
for decades. Knowledge of the magnitude of the risk associated with 
different electric devices is still incomplete. The aim of this study was to 
investigate the occurrence of EMI with different models of pacemakers 
and ICDs, both in vitro and in vivo. 
In addition, the new EMF Directive (2013/35/EU) requires precau-
tion and actions by the employer to ensure a safe working environment 
for the employees with a pacemaker/ICD. The purpose of this study was 
to estimate potential health risks for an employee who is returning to 
work after the implantation of a pacemaker/ICD, resulting from EMFs 
in the work environment. The lack of knowledge about the risks of EMFs 
can lead to hazardous situations in workplaces.
The specific aims of this study were as follows:
1. to investigate the susceptibility of pacemakers and ICDs to external 
electromagnetic fields, especially to low frequency magnetic fields. 
2. to determine threshold levels for interference: do they differ bet-
ween different pacemaker/ICD models when tested in vitro?
3. to evaluate the occurrence of EMI with pacemakers and ICDs caus-
ed by common environmental and occupational sources of EMFs.
4. to clarify a rare case of EMI with an ICD, induced by a laptop 
computer.
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4  METHods
4.1  In vitro studies
4.1.1  Exposure setup in laboratory tests
EMI between low frequency magnetic fields and pacemakers/ICDs was 
tested using a Helmholtz coil system to create magnetic fields. The coil 
system consisted of two coils with 17 turns and a radius of 37 cm. The 
distance between the two coils was also 37 cm. The test setup was com-
puter controlled using a graphical programming environment (Agilent 
VEE 7.5, Agilent Technologies, Inc., Santa Clara, CA, USA), a power 
amplifier (Kepco 20-20 Bipolar Power Amplifier, Kepco, Inc., Flushing, 
NY, USA), and a waveform generator (33220A Function Generator/
Arbitrary Waveform Generator, Agilent Technologies, Inc., Santa Clara, 
CA, USA). The current was recorded using a current meter equipped 
with a current shunt (Agilent 34411A Digital Multimeter and 34330A 
30 A Current Shunt, Agilent Technologies, Inc., Santa Clara, CA, USA). 
A schematic figure of the test setup is presented in Figure 1 of Article II.
The phantom used was a plastic box (29 cm x 22.5 cm x 5.5 cm) 
filled with physiological 0.9% NaCl solution. 0.9% NaCl solution was 
chosen to simulate the electrophysiological properties of human tissue. 
NaCl solution with different concentrations has been commonly used in 
many published in vitro studies [Bassen et al. 1998; Miller et al. 1998; 
Wilke et al. 1999; Barbaro et al. 1999; Gustrau et al. 2002; Angeloni et 
al. 2003; Tri et al. 204; Fukuta et al. 2005; Kainz et al. 2005; Gwechen-
berger et al. 2006; Brand et al. 2007; Della Chiara et al. 2007; Dubner 
et al. 2007; Bassen 2008; Seidman et al. 2010; Korpinen et al. 2012; 
Gomez et al. 2013]. The phantom with a single chamber pacemaker is 
presented in Figure 2 of Article I. The pacemaker/ICD under a test was 
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immersed in the solution and its electrode leads were arranged to match 
the worst-case scenario i.e., the loops formed by the leads were as large as 
possible and aligned to simulate the implanted pectoral left side position. 
This arrangement was important only when testing unipolar bradycardia 
pacemakers. With bipolar pacemakers and ICDs the arrangement of the 
lead loops does not affect the induction area. The distance between the 
pacemaker/ICD generator and the tip of the lead attached to the heart 
was circa 22 cm. This has been reported by Irnich to be the maximum 
distance between the generator and the tip and it forms an induction 
area of 190 cm2 with unipolar pacemaker system [Irnich 2002]. With 
bradycardia pacemakers the lengths of the leads used were 54, 58, and 
59 cm. With ICDs the defibrillation leads were 65 and 65 cm long, and 
the atrial and ventricular leads were 54, 58, and 59 cm, respectively. 
The additional lengths of the leads were looped under the pacemaker/
ICD generator case, as often done in real life implantations. Therefore, 
the total loop areas were approximately 204, 210, and 213 cm2 with 
bradycardia pacemakers and with unipolar systems. In case of multiple 
electrode leads, the leads were arranged so that the electrode tips didn’t 
touch each other in the phantom.
The phantom was placed between the two coils in the Helmholtz 
coil system during the tests. The measurements were conducted in three 
orthogonal directions between the coils: one with the magnetic field 
perpendicular to the pacemaker/ICD and two with the fields parallel to 
the device. Figure 3 shows the magnetic field directions.
Figure 3. Three orthogonal magnetic field directions (X,Y,Z) applied to pace-
maker/ICD.
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The pacemakers/ICDs were exposed to AC magnetic fields of four 
different waveforms: sine, pulse, ramp, and square-waves with frequen-
cies at a range of 2 Hz–1 kHz. The pulse width and edge time of the 
pulse waves were 0.1 ms and 5 ns. The rise and fall times for ramp waves 
were 1/(2f ), where f is the frequency of the wave. For square waves the 
rise/fall time is defined to be less than 13 ns in the specifications of the 
function generator. For sinusoidal fields, the exposure intensities used 
started approximately from the 1998 reference levels for occupational 
exposure given by the International Commission on Non-Ionizing 
Radiation Protection (ICNIRP) [ICNIRP 1998]. For non-sinusoidal 
waveforms the peak limits were determined with a magnetic field meter 
(Narda ELT 400, Narda Safety Test Solutions, Pfullingen, Germany). 
The magnetic field meter used operates at a frequency range of 1 Hz to 
400 kHz and provides flat frequency response with field strength meas-
urements. It uses the ICNIRP reference levels and peak limits derived 
from them for public and occupational exposure which correspond to 
the biological effects of the EMFs on humans. At frequencies below 50 
Hz, the highest sine-wave field levels were lower due to the limitations 
of the exposure equipment. At frequencies of 500 Hz and 1 kHz, the 
highest sine-wave levels used were little higher than the ICNIRP refer-
ence levels for occupational exposure. These exposure levels were chosen 
because they represent the safety-limits of a healthy worker and should 
not be exceeded in workplaces. The highest magnetic field flux densities 
used for every waveform and frequency are presented in Table 1.
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During the tests, the magnetic field intensities were decreased with each 
pacemaker/ICD until no interference occurred. The magnetic field in-
tensities were calculated using the analytical formula for Helmholtz coil 
and also measured with the field meter. All the tests were conducted in a 
laboratory that was electromagnetically shielded against external fields.
4.1.2  Pacemaker tests
Sixteen pacemakers from three manufacturers, Medtronic (Medtronic 
Inc., Minneapolis, MN, USA), Boston Scientific (Boston Scientific, 
Natick, MA, USA), and St. Jude Medical (St. Jude Medical, Sylmar, CA) 
were tested. Fourteen of the 16 pacemakers were explanted devices and 
two of them were demo pacemakers. All of the pacemakers tested were 
programmed to the highest programmable sensitivity settings varying 
from 0.1 mV to 1.0 mV and to the lowest possible arrhythmia detection 
f (Hz) Sine-wave Pulse-wave Ramp-wave Square-wave
Brms 
(mT)
Bocc  
(%)
Brms 
(mT)
Bocc 
(%)
Brms 
(mT)
Bocc  
(%)
Brms 
(mT)
Bocc  
(%)
2 580 1 160 100 170 100 230 100
5 580 7 41 100 130 100 230 100
10 580 20 12 100 130 100 220 100
25 580 60 8 100 120 100 200 100
50 500 100 11 100 110 100 180 100
60 410 100 - - 100 100 170 100
80 300 100 - - 99 100 160 100
100 240 100 14 100 95 100 150 100
500 58 120 - - 45 100 66 100
1000 39 110 - - 28 100 39 100
Brms is the calculated root-mean-square value of magnetic flux density.
Bocc refers to the ICNIRP 1998 reference level for occupational exposure to sinusoidal 
magnetic fields or the maximum peak limit for occupational exposure to non-
sinusoidal magnetic fields. The values in the column give the used magnetic field as 
percentage of Bocc.
Table 1. Maximum magnetic flux densities used in in vitro tests.
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rates. Ventricular and atrial high rate arrhythmia detection rates varied 
from 60 bpm to 180 bpm, depending on the pacemaker model. Auto 
mode switch (AMS) detection/base rate was programmable in three of the 
pacemakers tested and in those it was programmed to be 75–140 bpm. 
All of the pacemakers tested had the lower or basal rate programmed as 
40 bpm and the operation modes used were SSI (6), SSIR (3), DDDR 
(4), and DDD (3). The models, modes, and most significant programmed 
parameters of the pacemakers tested are shown in Table 2 of Article I.
In most of the pacemakers tested, the electrode lead configurations 
were bipolar. Only in three pacemakers was the atrial sensing and pacing 
programmed as unipolar and in two pacemakers the ventricular sensing 
as bipolar and pacing as unipolar. The sensing and pacing polarities of 
each pacemaker tested are presented in Table 2 of Article I.
4.1.3  Icd tests
The ICDs tested, like the pacemakers, were explanted or demo devices 
and they were from the same three manufacturers as the pacemakers 
tested. Seventeen ICDs of 13 different models were tested and are pre-
sented in Table II of Article II. The devices were programmed to operate 
with the highest programmable sensitivity settings (0.15–0.2 mV) and in 
DDD (5), DDDR (1), VVI (10), and VVIR (1) modes. The VT detec-
tion rates were programmed to lowest programmable rate, varying from 
90 bpm to 130 bpm and the VF detection rates ≥182 or 180 bpm. Also 
the detection rates for atrial episodes: mode switch and atrial tachycardia 
were programmed to lowest programmable rate, varying from 120 bpm 
to 180 bpm. The lower rate for pacing was programmed to 40 bpm with 
all of the ICDs tested.
4.2  In vivo studies
All the volunteers included in this study were recruited from the Pace-
maker Clinic of Helsinki University Hospital. The criteria for participa-
tion were the person’s age (only working-aged volunteers) and the nature 
of heart disease (only clinically stable volunteers). The volunteers had a 
pacemaker or ICD from one of the three manufacturers: St. Jude Medi-
cal, Boston Scientific, or Medtronic. 
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The first group of volunteers underwent laboratory tests and tests with 
an electronic article surveillance gate, induction hob, and MIG-welding 
equipment. This group consisted of 11 volunteers with a bradycardia 
pacemaker and 13 with an ICD. The models and operating modes of the 
pacemakers and ICDs tested in the first group are presented in Tables 
1 and 2 of Article IV. 
Prior to the tests, the sensitivities of the bradycardia pacemakers 
were programmed as 1.0 mV for the ventricle and 0.18–0.5 mV for the 
atrium. Ventricular/atrial high rate or mode switch detection rates were 
programmed as 175–190 bpm. All the pacemakers were tested with two 
pacing settings in order to better detect possible episodes of undersens-
ing, oversensing, or mode switch. Firstly, the base rate of the pacemaker 
was programmed low enough (30–50 bpm) to favour the volunteer’s 
intrinsic rhythm. Secondly, the base rate was programmed high enough 
(60–90 bpm) to result in 100% pacing. Bipolar settings were used in 
all the pacemakers tested.
One pacemaker from each manufacturer was chosen to be tested also 
with unipolar sensing settings. These pacemakers were the ones of the 
volunteers 3, 5, and 8 presented in Article IV. The unipolar pacemakers 
were programmed to pace the heart with a rate higher than the volunteer’s 
intrinsic rhythm (base rates 75, 80, and 90 bpm) operating in modes DDD, 
VVI, and DDD, respectively. All the three pacemakers were programmed to 
have a ventricular sensitivity of 1.0 mV. In addition, the two physiological 
(DDD) pacemakers were programmed to have atrial sensitivity of 0.5 mV 
and atrial/ventricular tachycardia detection rate of 180 bpm.
The ICDs in the first group were tested only once with base rates 
30–60 bpm. Their sensitivities were set at 0.3–0.6 mV for the ventricle 
and 0.2 mV for the atrium. The VT detection rates were set at 120–150 
bpm and VF detection rates to 200–300 bpm. The VT detection was 
programmed to monitor possible tachyarrhythmia and possible shock 
therapies resulting from false detection of VT were disabled.
Real-time electrocardiography (ECG) was used to monitor the 
volunteers of the first group during the tests in order to immediately 
discover possible EMI in the pacemaker/ICD function and changes in 
the volunteer’s heart activity. The stored electrogram (EGM) recordings 
of each device were analysed after the tests in order to find out possible 
inappropriate episodes in the function of the device.
56
4 methods
The second group of volunteers consisted of 11 patients with a 
bradycardia pacemaker. Some of the volunteers were participants of the 
first group. The second group of volunteers underwent tests using two 
mobile phone base stations, an electric commuter train, and overhead 
high voltage transmission lines.
The models, modes, base rates, and sensitivities of the pacemakers 
tested in the second group are shown in Table 1 of Article V. In all the 
pacemakers, normal clinical programming with bipolar configuration 
was maintained and the pacemakers were only interrogated prior to the 
tests. Atrial tachycardia and ventricular high rate detections were on in 
eight of the pacemakers, with detection rates of 170–225 bpm. All of 
the six physiological pacemakers (DDD) had a mode switch feature on, 
with auto mode switch base rate of 40–90 bpm.
Each volunteer in the second group underwent an ambulatory three-
channel ECG recording during the tests. The beginning of every exposure 
was labeled with trigger button of the ECG recorder. This made it possible 
to link the exposure and the corresponding sections in the ECG. After the 
exposures, the ECG recordings were analysed and all the pacemakers were 
interrogated again in order to find out possible malfunctions due to EMI. 
The third volunteer test was a case study concerning a reported inci-
dent by one of the volunteers with an ICD. The person had been lying 
on the bed while using a laptop computer on his chest, right above the 
ICD. The ICD started to produce a beeping sound indicating that it had 
gone into magnet mode, blocking all possible tachyarrhythmia detec-
tions and therapies. After learning about this incident, it was decided to 
replicate the situation. The ICD was a Medtronic Marquis VR 7230 and 
it was programmed to ventricular pacing and sensing (VVI) mode with 
a lower rate of 30 bpm. The VT detection was programmed to monitor 
possible tachyarrhythmia on a zone of 188–207 bpm and VF detection 
to 207 bpm with 30-J therapy. Due to the possibility of an inappropriate 
shock due to the magnetic field of the laptop’s hard disk or the WLAN 
used, the VF therapies were turned off during the test, leaving only the 
detection on. ECG was monitored during the test.
The study design was approved by the Coordinating Ethics Commit-
tee of the Hospital District of Helsinki and Uusimaa. All volunteers were 
fully informed in writing of the study and gave their written consent 
prior to the study.
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4.2.1  laboratory tests
The laboratory tests were conducted with the same test set-up that was 
used in the in vitro tests, but the Helmholtz coil was different. The coil 
consisted of two identical coils with 25 turns and a radius of 54 cm. 
The distance between the two coils was 57 cm. During the tests, the 
volunteers of the first group sat between the coils with his/her chest in 
the middle of the coils. The magnetic field was parallel to the chest-back 
axis of the volunteers.
Three different magnetic field exposure set-ups with varying wave-
forms, frequencies, and intensities were used to test EMI with the pace-
makers and ICDs of the first volunteer group. In every exposure set-up 
the duration of an exposure to a specific magnetic field was 10 s, followed 
by a rest of 10 s after each exposure. The Exposure Set-up I (Table 2) was 
chosen to comply with European Standard EN 50527-1, according to 
which pacemakers and ICDs are expected to work uninfluenced when 
magnetic flux density does not exceed 100 µT at 50 Hz [CENELEC 
2010]. The percentages of occupational and public exposure reference 
levels relate to the guidelines given by the ICNIRP in 1998 for sinusoi-
dal magnetic fields [ICNIRP 1998]. The peak limits for non-sinusoidal 
waveforms were derived from the corresponding ICNIRP reference 
levels. The exposure levels used were chosen to be less than the ICNIRP 
1998 reference levels for occupational exposure which represented the 
safety limits before the new ICNIRP reference levels in 2010 [ICNIRP 
2010]. EMFs higher than these reference levels were not allowed even 
for healthy workers, and possible risks would have increased if higher 
exposure levels had been used.
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The Exposure Set-ups II and III (Table 3) were chosen to be consistent 
with the waveforms and frequencies that were found to cause most of 
the EMI in in vitro studies of Articles I and II.
f 
(Hz)
Sine-wave Pulse-wave Ramp-wave Square-wave
Brms 
(µT)
Bocc/
Bpub  
(%)
Brms 
(µT)
Bocc/
Bpub 
(%)
Brms 
(µT)
Bocc/
Bpub 
(%)
Brms 
(µT)
Bocc/
Bpub 
(%)
2 110 0.22/1.1 3.5 35/170 100 47/230 100 27/140
5 100 1.3/6.3 1.9 35/170 100 47/240 100 26/130
10 100 4.0/20 2.5 35/170 100 47/230 100 28/140
25 98 9.8/49 3.7 35/170 97 53/260 96 31/150
50 95 20/99 4.8 35/170 95 61/310 95 38/190
60 95 23/110 5.0 35/170 95 64/320 95 41/200
100 94 38/190 5.6 35/170 94 77/380 94 50/250
200 93 75/370 6.1 35/170 67 79/400 94 75/370
Brms is the measured root-mean-square value of magnetic flux density.
Bocc/Bpub refers to the ICNIRP 1998 reference levels for occupational and public 
exposure to sinusoidal magnetic fields or the maximum peak limits for occupational 
and public exposure to non-sinusoidal magnetic fields. The values in the column 
give the magnetic field used as a percentage of Bocc and Bpub.  
Table 2. Maximum magnetic flux densities used in Exposure Set-up I 
of the in vivo tests.
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Exposure Set-up I was used to test all of the volunteers of the first group 
with bipolar bradycardia pacemakers and ICDs. Five of the volunteers 
were also tested with Exposure Set-up II and 12 with Exposure Set-up 
III. The three unipolarly programmed pacemakers were tested only with 
Exposure Set-up III with unipolar settings.
4.2.2  Electronic article surveillance (EAs) gate, 
induction hob, and MIg-welding machine
All the volunteers of the first group with a pacemaker or ICD underwent 
interference tests with an EAS gate, induction hob, and MIG-welding 
equipment.
f (Hz) Waveform Exposure set-up II Exposure set-up III
Brms (µT) Bocc/Bpub  (%) Brms (µT) Bocc/Bpub (%)
25 sine 170 17/85 300 30/150
50 sine 170 35/170 240 50/250
60 sine 170 41/200 220 53/260
100 sine 160 66/330 160 65/320
2 ramp 160 74/370 160 74/370
5 ramp 170 76/380 160 76/380
10 ramp 160 74/370 160 74/370
25 ramp 140 74/370 130 74/370
2 square 180 47/240 290 75/380
5 square 180 45/230 300 75/380
10 square 180 47/240 280 76/380
25 square 170 56/280 230 76/380
50 square 170 67/340 190 75/370
60 square 170 72/360 170 75/380
Brms is the measured root-mean-square value of magnetic flux density.
Bocc/Bpub refers to the ICNIRP 1998 reference levels for occupational and public 
exposure to sinusoidal magnetic fields or the maximum peak limits for occupational 
and public exposure to non-sinusoidal magnetic fields. The values in the column 
give the magnetic field used as a percentage of Bocc and Bpub.
Table 3. Maximum magnetic flux densities used in Exposure Set-ups II 
and III of the in vivo tests.
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The EAS gate used in the tests was a Sensormatic AMS-1080 acou-
stomagnetic gate (Sensormatic Electronics Corporation, Boca Raton, 
FL, USA), operating at a frequency of 58 kHz (±200 Hz). In the test 
protocol, the volunteer first walked past the gate four times at normal 
speed and at a distance of 10–20 cm. After that he/she stood in front of 
the gate for 1 min, with his/her chest almost touching it. 
In front of the EAS gate, at the height of 140 cm, the measured 
root-mean-square (rms) value of the magnetic flux density was 23 µT 
and the peak value was 210 µT. These values correspond 2590% of the 
peak limit derived from the ICNIRP 1998 reference levels for public 
exposure and 660% for occupational exposure. At the distance of 20 
cm from the surface of the gate and at the same height, the rms value of 
the magnetic flux density was 10 µT and the peak value 83 µT. These 
values correspond 1000% of the peak limit derived from the ICNIRP 
1998 reference levels for public exposure and 260% for occupational 
exposure. Figure 4 shows an oscilloscope picture of the waveform emitted 
by the EAS gate measured at the hight of 140 cm and with the distance 
of 20 cm from the gate.
Figure 4. An example of the waveform emitted by the EAS gate used in 
the in vivo tests as shown in the oscilloscope. The voltage (mV) axes are in 
arbitrary units.
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The induction hob used was a UPO A420014 (UPO, Lahti, Finland) 
household cooktop/oven, equipped with four cooking plates. During 
the tests, both front cooking plates were set at maximum heating power, 
with the boost function on. Two pots filled with water were placed on 
the front cooking plates. During the first phase of the test protocol, the 
volunteer stood in front of the cooktop for 1 min. In the second phase, 
the volunteer held the handles of one of the pots standing in front of the 
hob for 1 min. Thirdly, the volunteer lifted one of the pots to a cooking 
plate at the back of the hob, then stayed in front of the hob for 1 min.
The main operating frequency of the hob was 48 kHz. The magnetic 
flux density in front of the hob was 2 µT (corresponding 10% of the 
peak limit derived from the ICNIRP 1998 reference levels for public 
exposure and 7% of the corresponding limit for occupational exposure) 
at 40 cm above the cooking plates. The magnetic flux density was 3 µT 
(corresponding 130% of the peak limit derived from the ICNIRP 1998 
reference levels for public exposure and 30% of the corresponding limit 
for occupational exposure) directly above the plates at a height of 35 
cm while one of the pots was being lifted. During the lifting, most of 
the volunteers had to lean above the hob, so that their pacemaker/ICD 
was right above the cooking plate which still remained at the maximum 
heating power for few seconds after the removal of the pot.
Possible EMI with the pacemakers/ICDs of the volunteers of the first 
group was also tested with a Migatronic Automig 250 XE metal inert 
gas (MIG) -welding machine (Migatronic, Leicestershire, UK). The 
volunteers stood close to the welding cable for four few-second welding 
periods. The distance between the pacemaker/ICD and the cable was 40 
cm for six of the volunteers and 20 cm for eighteen volunteers.
Magnetic flux densities were measured during each welding period. 
The mean value of the magnetic flux density, at the distance of 40 cm, 
was 30 µT, with a standard deviation (SD) of 8 µT. At the distance of 20 
cm it was 93 µT with a SD of 29 µT, respectively. An oscilloscope picture 
of the waveform emitted by the welding cable is presented in Figure 5.
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Figure 5. An example of the waveform emitted by the welding cable used in 
the in vivo tests as shown in the oscilloscope. The voltage (mV, V) axes are in 
arbitrary units.
The pacemakers of three volunteers (3, 5, and 8) were also tested with 
unipolar sensing configuration. The tests with the welding cable were 
made at a distance of 20 cm between the cable and the pacemakers. The 
mean value of the magnetic flux density in these tests was 98 µT, with 
a SD of 20 µT.
4.2.3  Two mobile phone base stations, electric 
commuter train, overhead 400 kv high voltage 
transmission lines
The bradycardia pacemakers of the second volunteer group were exposed 
to EMF emitted by two mobile phone base stations, an electric commuter 
train and 400 kV high voltage transmission lines.
Two small indoor pico-size GSM base station transmitters, located 
next to each other on the wall, were tested for possible EMI with the 
pacemakers. The volunteers stood in front of the antennas for 30 seconds 
so that the distance between his/her pacemaker and the base stations 
was approximately 50 cm. The electric field measured at that point was 
16 V/m.
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The tests in electrically powered commuter train were conducted in 
two parts: first the volunteer sat on a bench attached to a thyristor cabinet 
while the train accelerated twice, then the volunteer stood in the hallway 
of the train, leaning against the thyristor cabinet while the train accel-
erated once. The magnetic flux density in the train was approximately 
170 µT measured above a bench attached to a thyristor cabinet while 
the train accelerated. The highest temporal magnetic flux density next 
to the thyristor cabined in the hallway was also measured approximately 
170 µT. The field levels at the two test sites varied slightly between the 
tests depending on the train’s level of acceleration. In Finland, electric 
trains use a 25 kV/50 Hz voltage, and the engines of the trains use an 
electric current varying from 300 to 600 A, depending on the driving 
speed. During acceleration the current can reach almost 1000 A [Jokela 
et al. 2006]. 
The EMI tests with 400 kV transmission lines were conducted while 
the volunteers walked around under the lines. The national grid company 
provided the details of the currents and voltages of the power lines at 
the time of the tests. These details were used to analytically calculate the 
magnetic and electric fields under the transmission lines. In all positions, 
the magnetic and electric field levels were less than 3 µT and 4 kV/m, 
respectively. 
4.2.4  laptop-computer
To replicate the situation that caused interference, the same laptop com-
puter (Hewlett-Packard eliteBook, Compaq 6930p, Hewlett-Packard 
Company, Palo Alto, CA, USA) was placed on the subject’s chest. The 
hard disk was located in the left corner, inside the computer, so that when 
using the computer in a lying position, the hard disk was situated right 
above the ICD. The magnetic flux density measured on the surface of 
the laptop casing closest to the hard disk was 3 µT for the time varying 
(AC) field and 11 mT for the static (DC) field. The situation was repeated 
with a wireless local area network (WLAN) connection activated.
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5.1  In vitro studies
5.1.1 Pacemaker tests
EMI was registered in six of the 16 pacemakers tested. The pacemakers 
tested and their models, modes, and the most relevant settings are pre-
sented in Table 2 of Article I. Three of the six devices that experienced 
EMI during the tests malfunctioned only with sine-wave magnetic 
fields. These pacemakers were all programmed with bipolar sensing 
and pacing settings. Two of the pacemakers that suffered interference 
malfunctioned with pulse, ramp, and square-waves, and one with sine, 
ramp, and square-waves. These devices were the three pacemakers that 
were programmed with unipolar atrial sensing and pacing settings. All of 
the three unipolar pacemakers that malfunctioned exhibited EMI from 
magnetic fields below the ICNIRP 1998 peak limits for general public 
exposure [ICNIRP 1998]. EMI in three bipolar pacemakers occurred 
only well above the ICNIRP reference levels for general public exposure 
[ICNIRP 1998]. The interference thresholds for each malfunctioned 
pacemaker are shown in Table 4.
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5 results
Two of the three bipolar pacemakers that malfunctioned, INSIGNIA 
I AVT VDD 0882 and PULSAR MAX II DR DDDR 1280, exhibited 
false ventricular tachycardia detections and atrial tachycardia detections/
responses. The third bipolar pacemaker, ZEPHYR XL DR5826, experi-
enced mode switch episodes. An example of INSIGNIA’s false detection 
of ventricular tachycardia is shown in Figure 6.
Figure 6. Ventricular tachycardia detection leading to complete loss of pac-
ing with pacemaker INSIGNIA I AVT VDD 0882, using sine wave with 50 Hz 
and 500 µT (= 100% of the ICNIRP’s 1998 reference level for occupational 
exposure). (VP = ventricular pacing, VS = ventricular sensing)
Two of the three unipolar pacemakers showing malfunctioning were of 
the same model, PULSAR MAX II DR DDDR 1280, and programmed 
in the same way. They experienced EMI, atrial tachycardia detection and 
response, quite similarly. The third unipolar pacemaker, VICTORY XL 
DR 5816, experienced mode switch episodes and with almost completely 
different magnetic fields than the other two unipolar pacemakers that 
malfunctioned.
Most of the EMI occurred when the pacemaker (generator case and 
the area formed by its electrode leads) was perpendicular to the external 
magnetic field, e.g., the magnetic field was applied from direction z as 
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shown in Figure 3. Three of the six malfunctioning pacemakers also had 
some interference with magnetic fields parallel to them (magnetic field 
direction x or y in Figure 3). 
5.1.2  ICD tests
Eleven of the 17 ICDs tested experienced EGM-registered EMI during 
the tests. These ICDs registered EMI with sine, ramp and/or square 
waveforms. The pulse waves interfered with none of the ICDs. EMI 
occurred only when the magnetic field was perpendicular (magnetic 
field applied from direction z in Figure 3) to the ICD tested. Parallel 
(applied from direction x or y in Figure 3) magnetic fields did not cause 
registered malfunctions.
Four kinds of malfunctions occurred during the tests. Six of the 17 
ICDs tested experienced false VT detection and three of them false VF 
detection. Four of the six dual chamber devices falsely detected atrial tachy-
cardia which resulted in AMS. In addition, tachycardia sensing occurred 
during atrial or ventricular refractory periods resulting in noise reversion 
in one of the 17 ICDs. The types of the malfunctions experienced by each 
of these 11 devices are presented in Table III of Article II. An example of 
falsely detected VT of an ICD device is presented in Figure 7.
Figure 7. False detection of ventricular tachycardia by an ICD. A sine-wave 
magnetic field (60 Hz, 410 µT) produced an artifact of ventricular tachycardia 
and made the ICD to switch to noise mode (DDI). The interference lasted 10 s 
which is equal to the time the magnetic field was applied. The ICD in ques-
tion was St. Jude Medical PROMOTE RF 3213-36.
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All recorded malfunctions of the ICDs occurred above the ICNIRP 
reference levels for general public or above peak levels derived from them 
[ICNIRP 1998]. The interference threshold levels that did not cause 
EMI with any of the ICDs tested are presented in Table 5.
f (Hz) Sine-wave Ramp-wave Square-wave
Brms 
(µT)
Bocc/Bpub (%) Brms 
(µT)
Bocc/Bpub (%) Brms 
(µT)
Bocc/Bpub (%)
2 83 65/320 140 65/320
5 41 33/160 70 33/160
10 570 23/110 45 33/160 70 33/160
25 390 39/200 74 64/320 140 68/340
50 180 36/180 99 91/450 120 67/330
60 170 41/200 95 89/440 110 67/330
80 160 51/260 87 85/420 100 66/330
100 180 72/360 95 65/330
Brms is the calculated root-mean-square value of magnetic field flux density.
Bocc/Bpub refers to the ICNIRP 1998 reference levels for occupational and public 
exposure to sinusoidal magnetic fields or the maximum peak limits for occupational 
and public exposure to non-sinusoidal magnetic fields. The values in the column 
give the magnetic field used as a percentage of Bocc and Bpub.   
Table 5. The results of the in vitro ICD tests. Interference threshold 
levels for the ICDs that exhibited malfunctions at ICNIRP 1998 
reference levels or derived peak limits for occupational exposure or 
below them, representing the fields in which malfunctions did not 
appear with any of the ICDs tested.
5.2  In vivo studies
5.2.1  laboratory tests
The laboratory tests, conducted with the volunteers of the first group, did 
not lead to any detected EMI between the magnetic fields and bipolar 
pacemakers or ICDs. 
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However, all of the three pacemakers of volunteers 3, 5, and 8, pro-
grammed with unipolar sensing settings experienced EMI in Exposure 
Set-up III. The unipolar pacemaker of Volunteer 3 experienced intermit-
tent and complete ventricular pacing at maximum tracking rate due to 
inappropriate atrial sensing during exposure to 25 Hz sine waves and 
to ramp and square waves at 2 and 5 Hz. These malfunctions were ob-
served in the ECG. The unipolar pacemaker of Volunteer 5 experienced 
intermittent or complete loss of pacing due to inappropriate ventricular 
sensing during exposure to 25 and 50 Hz sine waves, 2, 5, 10, and 25 
Hz ramp waves and 2, 5, and 10 Hz square waves. Ventricular tachycar-
dia detections were also found in the stored EGM recordings. One of 
these VT detections is presented in Figure 8. The unipolar pacemaker 
of Volunteer 8 experienced EMI during the whole exposure in Exposure 
Set-up III. Complete or intermittent loss of pacing due to inappropriate 
ventricular sensing was found in the ECG during every exposure period 
in Exposure Set-up III. These were seen as inappropriate AMS episodes, 
reversions to noise mode, and detections of high ventricular rate in stored 
EGM. One of these noise mode reversions is presented in Figure 9.
Figure 8. Inappropriate ventricular tachycardia detection and complete loss 
of pacing stored in EGM due to inappropriate ventricular sensing in Expo-
sure Set-up III with the unipolarly programmed pacemaker of Volunteer 5.
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Figure 9. Stored EGM showing inappropriate atrial and ventricular sensing 
episode resulting first in loss of pacing and then causing reversion to noise 
mode (DOO pacing) and an inappropriate AMS episode during Exposure 
Set-up III with the pacemaker of Volunteer 8 programmed to unipolar sens-
ing settings.
5.2.2  Electronic article surveillance (EAs) gate, 
induction hob and MIg-welding machine
No malfunctions were detected in the bipolar pacemakers or ICDs of the 
first group of volunteers during the tests with the EAS gate, induction 
hob or welding cable. 
However, the pacemaker of Volunteer 8 experienced EMI with the 
EAS gate and the welding cable when programmed with unipolar sens-
ing settings. The ECG showed inappropriate atrial sensing, resulting in 
ventricular pacing at the maximum tracking rate, when the volunteer 
was walking past the EAS gate. However, this did not happen when the 
volunteer stood in front of the gate for 1 min. During exposure to the 
welding cable, the pacemaker of Volunteer 8 sensed atrial signals inap-
propriately, resulting first in ventricular pacing at maximum tracking rate 
and later in an AMS episode seen in the stored EGM. The volunteer also 
reported a heavy feeling in her chest. Due to the subjective feelings of 
the volunteer, the test was discontinued after two welding periods. The 
maximum magnetic flux densities measured during these two welding 
periods were 130 and 100 µT.
The unipolarly programmed pacemakers of Volunteers 3 and 5 did 
not experience any malfunction during the tests with the EAS gate, 
induction hob or welding cable. The unipolar pacemaker of Volunteer 
8 also functioned flawlessly during the induction hob test.
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5.2.3  Two mobile phone base stations, electric 
commuter train, overhead 400 kv high voltage 
transmission lines
During the exposure to the mobile phone base stations, commuter train, 
and transmission lines, none of the pacemakers of the second group of 
volunteers experienced EMI that could be observed from the continuous 
ECG recordings or from the stored EGMs.
5.2.4  laptop-computer
The ICD tested experienced EMI soon after the laptop-computer was 
placed on the chest of the volunteer. The ICD started to make the beeping 
sound and went into magnet mode. This malfunction occurred without 
any network connections on. When the experiment was repeated with 
a WLAN connection, the result was the same. As EMI occurred also 
without the WLAN connection, it was concluded that it was caused by 
the static magnetic field generated by the hard disk of the laptop. After 
the laptop was moved away from the ICD, the beeping stopped and the 
ICD returned to its normal mode. The conversion to magnet mode is 
the expected response of an ICD when a sufficiently large permanent 
magnet is situated above it.
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6  dIscussIon
Studies testing electromagnetic interference in pacemakers and ICDs 
have usually focused on a specific application, such as mobile phones, 
EAS gates or medical equipment. Studies with low frequency magnetic 
fields (excluding power line frequencies 50/60 Hz) are rare. Many stud-
ies have focused on sinusoidal waveforms and have seldom considered 
pulsed waves, although often the fields in industrial workplaces are non-
sinusoidal. However, there is a lack of knowledge of pacemaker/ICD 
EMI in low frequency magnetic fields and especially with non-sinusoidal 
waveforms. This study tried to give insight into possible EMI in these 
conditions and with some common occupational applications.
With the pacemakers tested in vitro, the malfunctions found were inap-
propriate detections of atrial and ventricular tachycardia and auto mode 
switch episodes. In false tachycardia detection, the pacemaker interprets 
external signals as intrinsic heartbeats. This can result in induction of 
real arrhythmias and/or bradycardia leading to asystole. It can also cause 
symptoms such as palpitations, low blood pressure and chest pain. Before 
a false AMS episode, the pacemaker interprets an external signal as atrial 
arrhythmia, which leads to the activation of AMS usually resulting in 
ventricular pacing. Atrial or ventricular pacing during inappropriate AMS 
can lead to asynchronous atrial pacing in DDI mode and asynchronous 
ventricular pacing in VVI mode, respectively. In addition, it can cause, 
though very rarely, arrhythmias and pump failure (pacemaker syndrome). 
None of the bipolar pacemakers of the volunteers tested in vivo ex-
perienced EMI during exposures to any of the waveforms of Exposure 
Set-ups I–III. However, only one of the 11 pacemakers tested in vivo were 
of exactly the same model as the three pacemakers that malfunctioned 
in the in vitro tests.
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Three pacemakers with unipolar atrial sensing and pacing were tested 
in vitro; they all experienced EMI resulting in atrial tachycardia detec-
tions and AMS. The three unipolar pacemakers tested in vivo using low 
frequency magnetic fields experienced inappropriate atrial or ventricular 
sensing resulting in ventricular pacing at the maximum tracking rate and 
in loss of pacing. In the electrogram records stored, these malfunctions 
were seen as ventricular tachycardia detections, AMS episodes, rever-
sion to noise mode and ventricular higher rate detections. The unipolar 
pacemakers experienced same kinds of malfunctions both in vitro and 
in vivo during exposures to low frequency magnetic fields, even though 
none of the devices were of the same model.
The malfunctions detected during the in vitro laboratory tests with 
the ICDs were false ventricular tachycardia and fibrillation detections, 
false detection of atrial tachycardia resulting in AMS, and tachycardia 
detection during atrial or ventricular refractory period resulting in noise 
reversion. In inappropriate VT or VF detection, the ICD interprets 
external signal as rapid intrinsic heartbeats and activates arrhythmia 
termination either by anti-tachycardia pacing or by a high voltage 
therapy shock. ATP and therapy shocks can induce real arrhythmias 
and, in addition, therapy shocks are usually extremely uncomfortable 
when received in a conscious state. In false AMS, the ICD interprets 
external signal as atrial arrhythmias and it results in asynchronous atrial 
or ventricular pacing, like in bradycardia pacemakers. In noise reversion, 
the inappropriate tachycardia detection during refractory period results 
also in inappropriate asynchronous pacing. None of these, or any other 
malfunctions could be detected in the in vivo laboratory tests, although 
the magnetic field intensities used in the in vivo Exposure Set-ups II and 
III were generally much higher than the field levels that induced EMI 
in ICDs in vitro using the same waveforms and frequencies. However, 
only two of the ICDs that malfunctioned in vitro were exactly the same 
models as those tested in vivo.
The major differences in results between the in vitro and in vivo tests 
raise a question about the use of these kinds of phantoms in EMI tests of 
pacemakers and ICDs. How reliable are the results obtained with phan-
tom tests using this kind of simple, electrically passive phantom and with 
phantom tests in general? One possibility could be to tests pacemakers/
ICDs in vivo right before the explantation of the device during the device 
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replacement and repeat the test in vitro with exactly same settings right 
after the explantation using different kinds of phantoms. This procedure 
could give valuable information about the validity of phantom tests and 
could help to improve phantom testing.
The EMI with an ICD was found in the case of laptop computer 
situated on the ICD and made the ICD convert to magnet mode. The 
test indicates that people with an ICD may be at serious risk during 
the common habit of lying on a bed and using a laptop. Standard EN 
50527-1 regards computers and other IT equipment (radio transmission 
equipment and wireless communication excluded) as compliant with 
active implanted medical devices [CENELEC 2010]. Static magnetic 
fields usually have a temporary effect of converting ICDs to magnet 
mode. However, in some ICD models the effects of static magnetic fields 
can be permanent. With certain programming in some ICD models, 
arrhythmia detection and therapy can be permanently deactivated in 30 
seconds by a magnet. This can cause a serious risk to the health and life 
of a person with an ICD [Rasmussen et al. 2002; Hauser et al. 2004].
The appliances chosen for this study to test pacemaker/ICD EMI in 
real life situations (EAS gate, induction hob, welding cable, mobile phone 
base stations, electric commuter train, and high voltage power lines) were 
among those that have previously been reported to cause interference 
with implanted devices or that raise questions about pacemaker/ICD 
safety. Though they do not emit the highest EMFs that can be found at 
workplaces, they all are common applications of various occupational 
environments. Check-outs in many stores are positioned close to EAS 
gates and cashiers stand or sit next to them during their entire work shift. 
Induction cooking/heating and welding are widely used in several occu-
pations. EMF exposure from mobile base stations may not be relevant to 
most workers, because base stations antennas are normally located near 
the roof, far away from normal working environments. However, areas 
with field levels similar to those measured in this study may be accessed 
by technical personnel installing and maintaining the base stations. 
Public transportation, like commuter trains, is a global source of EMFs 
to both, employees and passengers, and high voltage transmission lines 
can produce relatively high electric and magnetic fields in the surround-
ing area and below. These fields emitted by power lines are reported as 
possibly interfering with the operation of pacemakers [Toivonen et al. 
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1991; Trigano et al. 2005B; Della Chiara et al. 2007; Korpinen et al. 
2012]. This can cause EMI with a pacemaker of a worker maintaining 
the lines. Although no traces of EMI was found between the transmission 
lines and the pacemakers tested in this study, high voltage transmission 
lines still remain a potential source of EMI. 
The unipolar pacemakers tested in this study, both in vitro and in vivo, 
were found to be more susceptible to external EMFs than the pacemakers 
tested with bipolar settings. This finding is consistent with the results of 
several other studies [Toivonen et al 1991; Wilke et al. 1998; Trigano 
et al. 2005B; Della Chiara et al. 2007]. However, in vitro laboratory 
studies with low frequency magnetic fields also showed EMI in bipolar 
pacemakers at quite low field intensities. Although no pacemaker/ICD 
malfunctioning was found in in vivo tests in the relatively high magnetic 
fields used, the new ICNIRP guideline of 1 000 µT for occupational 
exposure (at 50 Hz) may be too high for most workers with a pacemaker/
ICD [ICNIRP 2010]. The results of the in vivo tests of this study indicate 
that in the case of a worker with a bipolar pacemaker or an ICD, the 
exposure limits for the general public given by the European Council 
Recommendation (1999/519/EC) could be applied [The Council of the 
European Union 1999]. However, when a worker receives a unipolar 
pacemaker a more specific risk assessment is needed when the EMFs 
in the workplace are near or exceed the exposure limits for the general 
public. The magnetic flux densities that were used in this study to expose 
the unipolar pacemakers in vivo were much higher than the ICNIRP 
1998 guidelines for public exposure [ICNIRP 1998]. Hence, more in 
vivo research is needed before these public exposure limits can be used 
as “safety-levels” with unipolar pacemakers.
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7  conclusions
The volunteer tests with cardiac pacemakers and ICDs indicate that 
modern arrhythmia devices are well shielded against low frequency 
magnetic fields even at electromagnetically hostile workplaces. Unipo-
lar pacemakers were found to be much more sensitive to the magnetic 
fields applied in both, in vitro and in vivo laboratory tests than bipolar 
devices. The appliances tested – EAS gate, induction hob, MIG-welding 
cable, mobile phone base stations, electric commuter train, and 400 kV 
transmission power lines – do not seem to pose a high health risk with 
modern bipolar pacemakers. Unipolar pacemakers, on the other hand, 
can be affected by EMFs of common everyday applications, such as EAS 
gates at stores, and thus should be avoided when possible. The findings 
of the in vitro tests, however, leave questions about the possibility of 
EMI even with bipolar pacemakers and ICDs.
Laptop computers, positioned above the chest, can cause EMI with 
ICDs as shown by the findings of this study.
The results indicate that the commonly used magnetic field “safety-
limit” for pacemakers, corresoponding to the 1998 ICNIRP reference 
level for public exposure, B=100 µT (at 50 Hz), may be too high, espe-
cially for unipolar pacemakers. Based on the results of this study, it is 
not possible to derive general “safety-limits” or thresholds for EMI on 
pacemakers and ICDs. Each device needs to be programmed individually, 
and each patient as well as the work environment is different. In addition 
to intensity, the occurrence of EMI depends greatly on the frequency, 
waveform, and direction of the external electromagnetic field. Also 
the person’s dependency on the pacemaker and the severity of possible 
device malfunctions to his/her cardiac condition are important aspects 
when evaluating the consequences of EMI. Due to this, an individual 
78
7 conclusions
health risk assessment needs to be carried out in the workplace for every 
worker returning to work after a pacemaker or ICD implantation. In 
most workplaces such risk assessments will be rather straightforward, as 
workplace EMFs are in general much lower than those tested and found 
not to interfere with bipolar pacemakers and ICDs in the in vivo tests 
of this study. 
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. 
The risk of electromagnetic interference (EMI) with cardiac 
pacemakers and implantable cardioverter-defibrillators (ICDs) is of 
increasing concern in occupational environments. The number of 
workers with a pacemaker or ICD is growing rapidly. Knowledge 
is still insufficient concerning sources of EMI and the susceptibility 
of pacemakers and ICDs to electromagnetic fields (EMFs). In 
workplaces with strong EMFs, employees are often required to 
change tasks or retire after receiving a pacemaker/ICD. This study 
investigates the occurrence of EMI with pacemakers and ICDs 
in different magnetic fields and occupational environments and 
estimates potential EMF risks for an employee returning to work 
after a pacemaker/ICD implantation.
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